91˰涶

Professor Kerry-Anne Rye

Professor Kerry-Anne Rye

Professor

BSc (Hons), PhD, FAHA

Medicine & Health
School of Biomedical Sciences

Biography

Kerry-Anne Rye obtained her PhD from Flinders University of South Australia in 1986 and gained her postdoctoral training at The University of Illinois at Urbana-Champaign. She is a Research Professor, Head of the Cardiometabolic Disease Research Group and Deputy Head of the School of Biomedical Sciences, University of New South Wales. She is Editor-in-Chief of the Journal of Lipid Research and a Senior Guest Editor of The Journal of the American Heart Association Professor Rye is a Past Chair of the American Heart Association ATVB Council and Immediate Past-Chair of the American Heart Association ATVB Council Nominations Committee.

Research Program

Professor Rye co-leads the Cardiovascular and Metabolic Disease group with Associate Professor Shane Thomas. The overarching goal of Professor Rye's research program is to improve understanding of the causes of heart disease (atherosclerosis) and diabetes and to develop novel strategies for treating both diseases. Professor Rye studies signal transduction pathways in multiple cell types (macrophages and endothelial cells for heart disease and pancreatic beta cells and skeletal muscle cells for diabetes) and works withnovel animal models and state-of-the-art imaging techniques to identify new therapeutic targets for atherosclerosis and diabetes.She was the first to report that the atheroprotective high density lipoproteins (HDLs) in human plasma inhibit inflammation in coronary arteries, and that HDLs also have anti-diabetic properties.

Current Postdoctoral Fellows

Elias Glaros

Blake Cochran

Jaqueline Ku

Carmen Zhang

Nana Pham

Current PhD Students

Thomas King

Samson Ogumodede

Iqra Haleem

Current Honours Students

William Wang

Research Opportunities

There are opportunities for Honours, MSc and PhD students in theRye/Thomas Group research program. Contact Kerry-Anne Rye (k.rye@unsw.edu.au) for details of specific projects.

Phone
+61 2 9385 1219
Location
School of Medical Sciences Level 4E, Wallace Wurth Building High St, Kensington Sydney NSW 2052 Australia
  • Book Chapters | 2024
    Rakhshanda S; Liaw ST; Rhee J; Rye KA; Jonnagaddala J, 2024, 'Strategies to Address Statin Medication Intolerance Among Patients at Risk of Cardiovascular Disease Identified Through Electronic Health Records: A Literature Review and Pooled Analysis', in , pp. 132 - 136,
    Book Chapters | 2022
    Cochran BJ; Manandhar B; Rye KA, 2022, 'HDL and Diabetes', in HDL Metabolism and Diseases, pp. 119 - 127,
    Book Chapters | 2021
    Rye K-A; Barter PJ, 2021, 'Lipid-Lowering Drugs', in Encyclopedia of Molecular Pharmacology, Springer International Publishing, pp. 1 - 8,
    Book Chapters | 2010
    Rye K-A; Barter PJ, 2010, 'HDL Structure, Function, and Antiinflammatory Properties', in High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease, Springer New York, pp. 45 - 53,
    Book Chapters | 2008
    Barter PJ; Rye KA, 2008, 'HDL and Atherosclerosis', in High-Density Lipoproteins: From Basic Biology to Clinical Aspects, pp. 491 - 505,
    Book Chapters | 2008
    Siggins S; Rye KA; Olkkonen VM; Jauhiainen M; Ehnholm C, 2008, 'Human Plasma Phospholipid Transfer Protein (PLTP) - Structural and Functional Features', in High-Density Lipoproteins: From Basic Biology to Clinical Aspects, pp. 183 - 205,
    Book Chapters | 2002
    Barter P; Baker P; Gamble J; Vadas M; Rye K-A, 2002, 'Anti-Inflammatory Properties of High Density Lipoproteins', in Medical Science Symposia Series, Springer US, pp. 95 - 101,
    Book Chapters |
    Barter PJ; Clay MA; Rye K-A, 'High Density Lipoproteins', in Plasma Lipids and Their Role in Disease, Taylor & Francis, pp. 85 - 85,
    Book Chapters |
    Rye K-A; Clay MA; Barter PJ, 'Overview of Plasma Lipid Transport', in Plasma Lipids and Their Role in Disease, Taylor & Francis, pp. 1 - 16,
  • Journal articles | 2024
    Kopecky C; Haug M; Reischl B; Deshpande N; Manandhar B; King TW; Lee V; Wilkins MR; Morris M; Polly P; Friedrich O; Rye KA; Cochran BJ, 2024, 'Effect of insulin insufficiency on ultrastructure and function in skeletal muscle', Journal of Cachexia, Sarcopenia and Muscle, 15, pp. 112 - 123,
    Journal articles | 2024
    Manandhar B; Pandzic E; Deshpande N; Chen SY; Wasinger VC; Kockx M; Glaros EN; Ong KL; Thomas SR; Wilkins MR; Whan RM; Cochran BJ; Rye KA, 2024, 'ApoA-I Protects Pancreatic β-Cells from Cholesterol-Induced Mitochondrial Damage and Restores Their Ability to Secrete Insulin', Arteriosclerosis, Thrombosis, and Vascular Biology, 44, pp. E20 - E38,
    Journal articles | 2024
    Quinn M; Zhang RYK; Bello I; Rye KA; Thomas SR, 2024, 'Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction', Antioxidants, 13,
    Journal articles | 2024
    Tucker WJ; Tucker B; Januszewski AS; Jenkins AJ; Keech AC; Kestenbaum BR; Allison MA; Rye KA; Ong KL, 2024, 'Association of circulating fibroblast growth factor 21 levels with all-cause and cardiovascular mortality: The multi-ethnic study of atherosclerosis', Clinica Chimica Acta, 555,
    Journal articles | 2023
    Chen SY; Beretta M; Olzomer EM; Shah DP; Wong DYH; Alexopoulos SJ; Aleksovska I; Salamoun JM; Garcia CJ; Cochran BJ; Rye KA; Smith GC; Byrne FL; Morris MJ; Santos WL; Cantley J; Hoehn KL, 2023, 'Targeting negative energy balance with calorie restriction and mitochondrial uncoupling in db/db mice', Molecular Metabolism, 69,
    Journal articles | 2023
    Cook M; Tucker B; Patel S; Rye K; Ong K, 2023, 'The Association Between Sex Hormones and Incident Stroke', Heart, Lung and Circulation, 32, pp. S418 - S418,
    Journal articles | 2023
    King TW; Cochran BJ; Rye KA, 2023, 'ApoA-I and Diabetes', Arteriosclerosis, Thrombosis, and Vascular Biology, 43, pp. 1362 - 1368,
    Journal articles | 2023
    Machet J; Park M; Richardson A; Carnell M; Mouat MA; Smith NJ; Turner N; Cochran BJ; Rye KA; Di Girolamo N, 2023, 'Type 2 diabetes influences intraepithelial corneal nerve parameters and corneal stromal-epithelial nerve penetration sites', Journal of Diabetes Investigation, 14, pp. 591 - 601,
    Journal articles | 2023
    Ong KL; Marklund M; Huang L; Rye KA; Hui N; Pan XF; Rebholz CM; Kim H; Steffen LM; Van Westing AC; Geleijnse JM; Hoogeveen EK; Chen YY; Chien KL; Fretts AM; Lemaitre RN; Imamura F; Forouhi NG; Wareham NJ; Birukov A; Jäger S; Kuxhaus O; Schulze MB; De Mello VD; Tuomilehto J; Uusitupa M; Lindström J; Tintle N; Harris WS; Yamasaki K; Hirakawa Y; Ninomiya T; Tanaka T; Ferrucci L; Bandinelli S; Virtanen JK; Voutilainen A; Jayasena T; Thalamuthu A; Poljak A; Bustamante S; Sachdev PS; Senn MK; Rich SS; Tsai MY; Wood AC; Laakso M; Lankinen M; Yang X; Sun L; Li H; Lin X; Nowak C; Ärnlöv J; Risérus U; Lind L; Le Goff M; Samieri C; Helmer C; Qian F; Micha R; Tin A; Köttgen A; De Boer IH; Siscovick DS; Mozaffarian D; Wu JHY, 2023, 'Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts', BMJ,
    Journal articles | 2023
    Sayanthan S; Allison MA; Budoff MJ; Rye KA; Ong KL, 2023, 'Relationship of fibroblast growth factor 21 with the prevalence and progression of vascular and valvular calcification: Multi-ethnic study of atherosclerosis', International Journal of Cardiology, 370, pp. 388 - 395,
    Journal articles | 2023
    Thomas SR; Zhang Y; Rye KA, 2023, 'The pleiotropic effects of high-density lipoproteins and apolipoprotein A-I', Best Practice and Research: Clinical Endocrinology and Metabolism, 37,
    Journal articles | 2023
    Tucker B; Ephraums J; King TW; Abburi K; Rye KA; Cochran BJ, 2023, 'Impact of Impaired Cholesterol 91˰涶ostasis on Neutrophils in Atherosclerosis', Arteriosclerosis, Thrombosis, and Vascular Biology, 43, pp. 618 - 627,
    Journal articles | 2023
    Tucker W; McClelland RL; Allison MA; Szklo M; Rye KA; Ong KL, 2023, 'The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis', Metabolism: Clinical and Experimental, 143,
    Journal articles | 2023
    Tucker W; Tucker B; Kestenbaum B; Alison M; Rye K; Ong KL, 2023, 'The Relationship of Circulating Fibroblast Growth Factor 21 Levels with All-Cause and Cardiovascular Mortality: The Multi-Ethnic Study of Atherosclerosis', Heart, Lung and Circulation, 32, pp. S403 - S403,
    Journal articles | 2023
    Tucker W; Tucker B; Rye KA; Ong KL, 2023, 'Fibroblast growth factor 21 in heart failure', Heart Failure Reviews, 28, pp. 261 - 272,
    Journal articles | 2023
    Wang H; Tucker WJ; Jonnagaddala J; Schutte AE; Jalaludin B; Liaw ST; Rye KA; Wong RK; Ong KL, 2023, 'Using machine learning to predict cardiovascular risk using self-reported questionnaires: Findings from the 45 and Up Study', International Journal of Cardiology, 386, pp. 149 - 156,
    Journal articles | 2023
    Zhang RYK; Cochran BJ; Thomas SR; Rye KA, 2023, 'Impact of Reperfusion on Temporal Immune Cell Dynamics After Myocardial Infarction', Journal of the American Heart Association, 12,
    Journal articles | 2022
    Darabi M; Lhomme M; Dahik VD; Guillas I; Frisdal E; Tubeuf E; Poupel L; Patel M; Gautier EL; Huby T; Guerin M; Rye KA; Lesnik P; Le Goff W; Kontush A, 2022, 'Phosphatidylserine enhances anti-inflammatory effects of reconstituted HDL in macrophages via distinct intracellular pathways', FASEB Journal, 36,
    Journal articles | 2022
    Guiney L; Glaros E; Vaisar T; Ooi S; Thomas S; Rye K, 2022, 'Longitudinal Analysis of the Effect of an Acute Coronary Syndrome on the Proteome of High-Density Lipoprotein', Heart, Lung and Circulation, 31, pp. S312 - S312,
    Journal articles | 2022
    Jose J; Hoque M; Engel J; Beevi SS; Wahba M; Georgieva MI; Murphy KJ; Hughes WE; Cochran BJ; Lu A; Tebar F; Hoy AJ; Timpson P; Rye KA; Enrich C; Rentero C; Grewal T, 2022, 'Annexin A6 and NPC1 regulate LDL-inducible cell migration and distribution of focal adhesions', Scientific Reports, 12,
    Journal articles | 2022
    Kadappu P; Jonnagaddala J; Liaw ST; Cochran BJ; Rye KA; Ong KL; Liaw T, 2022, 'Statin Prescription Patterns and Associations with Subclinical Inflammation', Medicina (Lithuania), 58, pp. 1096,
    Journal articles | 2022
    Liu Y; Castano D; Girolamo F; Trigueros-Motos L; Bae HG; Neo SP; Oh J; Narayanaswamy P; Torta F; Rye KA; Jo DG; Gunaratne J; Jung S; Virgintino D; Singaraja RR, 2022, 'Loss of ABCA8B decreases myelination by reducing oligodendrocyte precursor cells in mice', Journal of Lipid Research, 63,
    Journal articles | 2022
    May LT; Bartolo BA; Harrison DG; Guzik T; Drummond GR; Figtree GA; Ritchie RH; Rye KA; De Haan JB, 2022, 'Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discovery', Clinical Science, 136, pp. 1731 - 1758,
    Journal articles | 2022
    Ong KL; Cochran BBiotech BJ; Manandhar B; Thomas S; Rye KA, 2022, 'HDL maturation and remodelling', Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1867,
    Journal articles | 2022
    Raftopulos NL; Washaya TC; Niederprum A; Egert A; Hakeem-Sanni MF; Varney B; Aishah A; Georgieva ML; Olsson E; Dos Santos DZ; Nassar ZD; Cochran BJ; Nagarajan SR; Kakani MS; Hastings JF; Croucher DR; Rye K-A; Butler LM; Grewal T; Hoy AJ, 2022, 'Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover', CANCER & METABOLISM, 10,
    Journal articles | 2022
    Richardson A; Fok S; Lee V; Rye KA; Di Girolamo N; Cochran BJ, 2022, 'Use of High-Refractive Index Hydrogels and Tissue Clearing for Large Biological Sample Imaging', Gels, 8,
    Journal articles | 2022
    Shearston K; Tan JTM; Cochran BJ; Rye KA, 2022, 'Inhibition of Vascular Inflammation by Apolipoprotein A-IV', Frontiers in Cardiovascular Medicine, 9,
    Journal articles | 2022
    Stanton KM; Kienzle V; Dinnes DLM; Kotchetkov I; Jessup W; Kritharides L; Celermajer DS; Rye KA, 2022, 'Moderate-and High-Intensity Exercise Improves Lipoprotein Profile and Cholesterol Efflux Capacity in Healthy Young Men', Journal of the American Heart Association, 11,
    Journal articles | 2022
    Wu Y; Xu Y; Chen J; Zhao M; Rye KA, 2022, 'HDL and Endothelial Function', , 1377, pp. 27 - 47,
    Journal articles | 2022
    Xiong T; Paris VR; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA, 2022, 'Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model', American Journal of Physiology - Endocrinology and Metabolism, 323, pp. E145 - E158,
    Journal articles | 2022
    Zhong S; Chèvre R; Mayan DC; Corlianò M; Cochran BJ; Sem KP; van Dijk TH; Peng J; Tan LJ; Hartimath SV; Ramasamy B; Cheng P; Groen AK; Kuipers F; Goggi JL; Drum C; van Dam RM; Tan RS; Rye KA; Hayden MR; Cheng CY; Chacko S; Flannick J; Sim X; Tan HC; Singaraja RR, 2022, 'Haploinsufficiency of CYP8B1 associates with increased insulin sensitivity in humans', Journal of Clinical Investigation, 132,
    Journal articles | 2022
    Zipinotti dos Santos D; Santos Guimaraes ID; Hakeem-Sanni MF; Cochran BJ; Rye KA; Grewal T; Hoy AJ; Rangel LBA, 2022, 'Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells', Discover Oncology, 13,
    Journal articles | 2021
    Cochran B; Ong K; Rye K-A; Manandhar B, 2021, 'APOA1: a Protein with Multiple Therapeutic Functions', Current Atherosclerosis Reports,
    Journal articles | 2021
    Cochran BJ; Ong KL; Manandhar B; Rye KA, 2021, 'High density lipoproteins and diabetes', Cells, 10, pp. 850,
    Journal articles | 2021
    Di Bartolo BA; Cartland SP; Genner S; Manuneedhi Cholan P; Vellozzi M; Rye KA; Kavurma MM, 2021, 'HDL Improves Cholesterol and Glucose 91˰涶ostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis', Journal of Diabetes Research, 2021,
    Journal articles | 2021
    Ho JH; Ong KL; Cuesta Torres LF; Liu Y; Adam S; Iqbal Z; Dhage S; Ammori BJ; Syed AA; Rye K-A; Tabet F; Soran H, 2021, 'High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity.', J Lipid Res, pp. 100044,
    Journal articles | 2021
    Ho JH; Ong KL; Cuesta Torres LF; Liu Y; Adam S; Iqbal Z; Dhage S; Ammori BJ; Syed AA; Rye KA; Tabet F; Soran H, 2021, 'High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity', Journal of Lipid Research, 62, pp. 100043,
    Journal articles | 2021
    Hui N; Morris MJ; Allison MA; Tsai MY; Rye KA; Tabet F; Ong KL, 2021, 'Lipoprotein (a) and the risk of elevated depressive symptoms: The Multi-Ethnic Study of Atherosclerosis', Journal of Psychiatric Research, 133, pp. 119 - 124,
    Journal articles | 2021
    Manandhar B; Pandzic E; Deshpande N; Chen S-Y; Wasinger VC; Kockx M; Glaros E; Ong KL; Thomas S; Wilkins M; Whan R; Cochran BJ; Rye KA, 2021, 'The Anti-Oxidant Function Of Apolipoprotein A-I Rescues Pancreatic beta-Cells From Cholesterol-Induced Mitochondrial Dysfunction', ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 41,
    Journal articles | 2021
    Ong KL; McClelland RL; Allison MA; Cushman M; Garg PK; Tsai MY; Rye KA; Tabet F, 2021, 'Lipoprotein (a) and coronary artery calcification: prospective study assessing interactions with other risk factors', Metabolism: Clinical and Experimental, 116, pp. 154706,
    Journal articles | 2021
    Ong KL; Wu L; Januszewski AS; O’Connell R; Xu A; Scott RS; Sullivan DR; Rye KA; Li H; Ma RCW; Li L; Gebski V; Jenkins AJ; Jia W; Keech AC, 2021, 'The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study', Diabetes and Vascular Disease Research, 18,
    Journal articles | 2021
    Rohatgi A; Westerterp M; Eckardstein AV; Remaley A; Rye KA, 2021, 'HDL in the 21st Century', Circulation, 143, pp. 2293 - 2309,
    Journal articles | 2021
    Rye KA; Davidson NO; Burlingame AL; Guengerich FP, 2021, 'Working Toward Reducing Bias in Peer Review', Canadian Journal of Surgery, 64,
    Journal articles | 2021
    Rye KA; Davidson NO; Burlingame AL; Guengerich FP, 2021, 'Working toward reducing bias in peer review', Journal of Biological Chemistry, 279,
    Journal articles | 2021
    Rye KA; Davidson NO; Burlingame AL; Peter Guengerich F, 2021, 'Working toward reducing bias in peer review', Journal of Lipid Research, 62,
    Journal articles | 2021
    Sawant S; Tucker B; Senanayake P; Waters DD; Patel S; Rye KA; Ong KL; Cochran BJ, 2021, 'The association between lipid levels and leukocyte count: A cross-sectional and longitudinal analysis of three large cohorts', American Heart Journal Plus: Cardiology Research and Practice, 4,
    Journal articles | 2021
    Sawant S; Tucker B; Senenayake P; Waters D; Rye K; Patel S; Ong K; Cochran B, 2021, 'The Association Between Lipid Levels and Leukocyte Count: A Cross-Sectional and Longitudinal Analysis of Three Large Cohorts', Heart, Lung and Circulation, 30, pp. S245 - S245,
    Journal articles | 2021
    Tucker B; Sawant S; McDonald H; Rye KA; Patel S; Ong KL; Cochran BJ, 2021, 'The association of serum lipid and lipoprotein levels with total and differential leukocyte counts: Results of a cross-sectional and longitudinal analysis of the UK Biobank', Atherosclerosis, 319, pp. 1 - 9,
    Journal articles | 2021
    Vaidya K; Tucker B; Kurup R; Khandkar C; Pandzic E; Barraclough J; Machet J; Misra A; Kavurma M; Martinez G; Rye KA; Cochran BJ; Patel S, 2021, 'Colchicine inhibits neutrophil extracellular trap formation in patients with acute coronary syndrome after percutaneous coronary intervention', Journal of the American Heart Association, 10, pp. 1 - 13,
    Journal articles | 2020
    Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'Opening ASBMB publications freely to all', Journal of Biological Chemistry, 295, pp. 7814 - 7815,
    Journal articles | 2020
    Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'Opening ASBMB publications freely to all', Journal of Lipid Research, 61, pp. 969 - 970,
    Journal articles | 2020
    Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'Opening ASBMB publications freely to all', Molecular and Cellular Proteomics, 19, pp. 914 - 915,
    Journal articles | 2020
    Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'The data must be accessible to all', Journal of Biological Chemistry, 295, pp. 4371,
    Journal articles | 2020
    Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'The data must be accessible to all', Molecular and Cellular Proteomics, 19, pp. 569 - 570,
    Journal articles | 2020
    Gogonea V; Peters J; Gerstenecker GS; Topbas C; Hou L; Combet J; Didonato JA; Smith JD; Rye KA; Hazen SL, 2020, 'Protein backbone and average particle dynamics in reconstituted discoidal and spherical HDL probed by hydrogen deuterium exchange and elastic incoherent neutron scattering', Biomolecules, 10,
    Journal articles | 2020
    Ho JH; Liu Y; Adam S; Syed AA; Ammori BJ; Donn R; Malik R; Tabet F; Cochran BJ; Rye K-A; Soran H, 2020, 'CHANGES IN THE EFFECT OF HDL ON PANCREATIC BETA-CELL INSULIN SECRETION FOLLOWING METABOLIC SURGERY', ATHEROSCLEROSIS, 315, pp. E150 - E151,
    Journal articles | 2020
    Manandhar B; Cochran BJ; Rye KA, 2020, 'Role of High-Density Lipoproteins in Cholesterol 91˰涶ostasis and Glycemic Control', Journal of the American Heart Association, 9,
    Journal articles | 2020
    Meneses-Salas E; García-Melero A; Kanerva K; Blanco-Muñoz P; Morales-Paytuvi F; Bonjoch J; Casas J; Egert A; Beevi SS; Jose J; Llorente-Cortés V; Rye KA; Heeren J; Lu A; Pol A; Tebar F; Ikonen E; Grewal T; Enrich C; Rentero C, 2020, 'Annexin A6 modulates TBC1D15/Rab7/StARD3 axis to control endosomal cholesterol export in NPC1 cells', Cellular and Molecular Life Sciences, 77, pp. 2839 - 2857,
    Journal articles | 2020
    Nazir S; Jankowski V; Bender G; Zewinger S; Rye KA; van der Vorst EPC, 2020, 'Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!', Advanced Drug Delivery Reviews, 159, pp. 94 - 119,
    Journal articles | 2020
    Ong KL; Chung RWS; Hui N; Festin K; Lundberg AK; Rye KA; Jonasson L; Kristenson M, 2020, 'Usefulness of Certain Protein Biomarkers for Prediction of Coronary Heart Disease', American Journal of Cardiology, 125, pp. 542 - 548,
    Journal articles | 2020
    Ong KL; McClelland R; Allison MA; Cushman M; Garg P; Tsai MY; Rye KA; Tabet F, 2020, 'Abstract 12911: Association of Lipoprotein (a) and Coronary Artery Calcification: Prospective Study Assessing Interactions With Other Risk Factors in the Multi-Ethnic Study of Atherosclerosis', Circulation, 142,
    Journal articles | 2020
    Ong KL; Wu L; Januszewski AS; O'Connell RL; Xu A; Rye KA; Ma RCW; Li H; Jenkins AJ; Jia W; Keech AC, 2020, 'Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study', Diabetes Research and Clinical Practice, 169, pp. 108450,
    Journal articles | 2020
    Rye KA; Davidson NO; Burlingame AL; Guengerich FP, 2020, 'Working toward reducing bias in peer review', Molecular and Cellular Proteomics, 20,
    Journal articles | 2020
    Shimabukuro Okuda L; Tallada Iborra R; Ramos Pinto P; Fabres Machado U; Corrêa-Giannella ML; Pickford R; Woods T; Brimble MA; Rye KA; Passarelli M, 2020, 'Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages', Mediators of Inflammation, 2020,
    Journal articles | 2020
    Smith RC; Bulanadi JC; Gill AJ; Rye KA; Hugh T; Proschogo N; Smith SF; Phillips L; Gong X; Julovi SM; Xue A; Moghaddam MJ, 2020, 'Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in mice', Cancer Letters, 495, pp. 112 - 122,
    Journal articles | 2020
    Stanton K; Kienzle V; Dinnes D; Jessup W; Kritharides L; Rye K; Celermajer D, 2020, '739 Moderate and High Intensity Exercise Improve Cholesterol Efflux Capacity, Lipoprotein Profile and Increase HDL Particle Size in Healthy Young Men', Heart, Lung and Circulation, 29, pp. S368 - S369,
    Journal articles | 2020
    Tabet F; Lee S; Zhu W; Levin MG; Toth CL; Cuesta Torres LF; Vinh A; Kim HA; Chu HX; Evans MA; Kuzmich ME; Drummond GR; Remaley AT; Rye KA; Sobey CG; Vickers KC, 2020, 'microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke', Journal of Cerebral Blood Flow and Metabolism, 40, pp. 1300 - 1315,
    Journal articles | 2020
    Tucker B; McClelland RL; Allison MA; Budoff MJ; Wu BJ; Barter PJ; Rye KA; Ong KL, 2020, 'Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease', Atherosclerosis, 299, pp. 38 - 44,
    Journal articles | 2020
    Tucker B; Vaidya K; Kurup R; Khandkar C; Barraclough J; Misra A; Kavurma M; Martinez G; Rye K-A; Cochran B; Patel S, 2020, 'COLCHICINE INHIBITS NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN ACUTE CORONARY SYNDROME PATIENTS POST PERCUTANEOUS CORONARY INTERVENTION', Journal of the American College of Cardiology, 75, pp. 1346 - 1346,
    Journal articles | 2020
    Tucker B; Vaidya K; Kurup R; Khandkar C; Pandzic E; Barraclough J; Misra A; Kavurma M; Martinez G; Rye K; Cochran B; Patel S, 2020, '461 Colchicine Inhibits Neutrophil Extracellular Trap Formation in Acute Coronary Syndrome Patients Post Percutaneous Coronary Intervention', Heart, Lung and Circulation, 29, pp. S244 - S244,
    Journal articles | 2020
    Weaver JC; Ullah I; Qi M; Giannakopoulos B; Rye KA; Kockx M; Kritharides L; Krilis SA, 2020, 'Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease', Arteriosclerosis, Thrombosis, and Vascular Biology, 40, pp. 2794 - 2804,
    Journal articles | 2019
    Anuwatmatee S; Allison MA; Shlipak MG; McClelland RL; Kramer H; Tang S; Hou L; Rye KA; Ong KL, 2019, 'Relationship of fibroblast growth factor 21 with kidney function and albuminuria: Multi-ethnic study of atherosclerosis', Nephrology Dialysis Transplantation, 34, pp. 1009 - 1016,
    Journal articles | 2019
    Anuwatmatee S; Tang S; Wu BJ; Rye KA; Ong KL, 2019, 'Fibroblast growth factor 21 in chronic kidney disease', Clinica Chimica Acta, 489, pp. 196 - 202,
    Journal articles | 2019
    Cochran B; Tang S; Tabet F; Cuesta Torres L; Wu B; Barter P; Rye K-A, 2019, 'Apolipoprotein A-I enhances insulin-dependent and insulinindependent glucose uptake by skeletal muscle', Scientific Reports
    Journal articles | 2019
    Cuesta Torres LF; Zhu W; Öhrling G; Larsson R; Patel M; Wiese CB; Rye KA; Vickers KC; Tabet F, 2019, 'High-density lipoproteins induce miR-223–3p biogenesis and export from myeloid cells: Role of scavenger receptor BI-mediated lipid transfer', Atherosclerosis, 286, pp. 20 - 29,
    Journal articles | 2019
    Gierasch LM; Burlingame AL; Davidson NO; Rye KA, 2019, 'For the sake of science', Journal of Biological Chemistry, 294, pp. 2976,
    Journal articles | 2019
    Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2019, 'For the sake of science', Journal of Lipid Research, 60, pp. 719 - 720,
    Journal articles | 2019
    Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2019, 'For the sake of science', Molecular and Cellular Proteomics, 18, pp. 406 - 407,
    Journal articles | 2019
    Hackett MJ; Hollings A; Majimbi M; Brook E; Cochran B; Giles C; Lam V; Nesbit M; Rye KA; Mamo JCL; Takechi R, 2019, 'Multimodal Imaging Analyses of Brain Hippocampal Formation Reveal Reduced Cu and Lipid Content and Increased Lactate Content in Non-Insulin-Dependent Diabetic Mice', ACS Chemical Neuroscience, 10, pp. 2533 - 2540,
    Journal articles | 2019
    Hou L; Tang S; Wu BJ; Ong KL; Westerterp M; Barter PJ; Cochran BJ; Tabet F; Rye KA, 2019, 'Apolipoprotein A-l improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1', FASEB Journal, 33, pp. 8479 - 8489,
    Journal articles | 2019
    Hui N; Barter PJ; Ong KL; Rye KA, 2019, 'Altered HDL metabolism in metabolic disorders: Insights into the therapeutic potential of HDL', Clinical Science, 133, pp. 2221 - 2235,
    Journal articles | 2019
    Kopecky C; Lytvyn Y; Domenig O; Antlanger M; Kovarik JJ; Kaltenecker CC; Poglitsch M; Perkins BA; Rye KA; Cherney DZI; Säemann MD, 2019, 'Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus', Diabetologia, 62, pp. 1090 - 1093,
    Journal articles | 2019
    Kopecky C; Pandzic E; Parmar A; Szajer J; Lee V; Dupuy A; Arthur A; Fok S; Whan R; Ryder WJ; Rye KA; Cochran BJ, 2019, 'Translocator protein localises to CD11b + macrophages in atherosclerosis', Atherosclerosis, 284, pp. 153 - 159,
    Journal articles | 2019
    Lai YC; Woollard KJ; McClelland RL; Allison MA; Rye KA; Ong KL; Cochran BJ, 2019, 'The association of plasma lipids with white blood cell counts: Results from the Multi-Ethnic Study of Atherosclerosis', Journal of Clinical Lipidology, 13, pp. 812 - 820,
    Journal articles | 2019
    Magdas A; Ding J; McClelland RL; Allison MA; Barter PJ; Rye KA; Ong KL, 2019, 'The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis', Scientific Reports, 9, pp. 16423,
    Journal articles | 2019
    Ong KL; Campbell S; Wu BJ; McClelland RL; Kokkinos J; Szklo M; Polak JF; Allison MA; Rye KA, 2019, 'Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis', Atherosclerosis, 287, pp. 46 - 53,
    Journal articles | 2019
    Ong KL; Hui N; Januszewski AS; Kaakoush NO; Xu A; Fayyad R; DeMicco DA; Jenkins AJ; Keech AC; Waters DD; Barter PJ; Rye KA, 2019, 'High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)', Metabolism: Clinical and Experimental, 93, pp. 93 - 99,
    Journal articles | 2019
    Ong KL; McClelland RL; Allison MA; Kokkinos J; Wu BJ; Barter PJ; Rye KA, 2019, 'Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis', Atherosclerosis, 281, pp. 200 - 206,
    Journal articles | 2019
    Rye KA; Davidson N, 2019, 'A letter from the editors-in-Chief', Journal of Lipid Research, 60, pp. 1,
    Journal articles | 2019
    Tucker B; Li H; Long X; Rye KA; Ong KL, 2019, 'Fibroblast growth factor 21 in non-alcoholic fatty liver disease', Metabolism: Clinical and Experimental, 101,
    Journal articles | 2019
    Wu BJ; Li Y; Ong KL; Sun Y; Johns D; Barter PJ; Rye KA, 2019, 'The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits', Scientific Reports, 9, pp. 16183,
    Journal articles | 2019
    Wu BJ; Sun Y; Ong KL; Li Y; Tang S; Barter PJ; Rye KA, 2019, 'Apolipoprotein A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats', Arteriosclerosis, Thrombosis, and Vascular Biology, 39, pp. 1160 - 1171,
    Journal articles | 2019
    Yuan D; Wu BJ; Henry A; Rye KA; Ong KL, 2019, 'Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review', Clinical Endocrinology, 90, pp. 47 - 55,
    Journal articles | 2018
    Aleidi SM; Yang A; Sharpe LJ; Rao G; Cochran BJ; Rye KA; Kockx M; Brown AJ; Gelissen IC, 2018, 'The E3 ubiquitin ligase, HECTD1, is involved in ABCA1-mediated cholesterol export from macrophages', Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1863, pp. 359 - 368,
    Journal articles | 2018
    Arsenault BJ; Petrides F; Tabet F; Bao W; Hovingh GK; Boekholdt SM; Ramin-Mangata S; Meilhac O; DeMicco D; Rye KA; Waters DD; Kastelein JJP; Barter P; Lambert G, 2018, 'Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk', Journal of Clinical Lipidology, 12, pp. 130 - 136,
    Journal articles | 2018
    Barter PJ; Cochran BJ; Rye KA, 2018, 'CETP inhibition, statins and diabetes', Atherosclerosis, 278, pp. 143 - 146,
    Journal articles | 2018
    Barter PJ; Rye KA, 2018, 'Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease Risk', Cardiology Clinics, 36, pp. 299 - 310,
    Journal articles | 2018
    Choteau SA; Cuesta Torres LF; Barraclough JY; Elder AMM; Martínez GJ; Chen Fan WY; Shrestha S; Ong KL; Barter PJ; Celermajer DS; Rye KA; Patel S; Tabet F, 2018, 'Transcoronary gradients of HDL-associated MicroRNAs in unstable coronary artery disease', International Journal of Cardiology, 253, pp. 138 - 144,
    Journal articles | 2018
    Cochran BJ; Pinheiro D; Prendecki M; Jones B; Cegla J; Lee V; Barter PJ; Murphy AJ; Rye K-A; Woollard KJ, 2018, 'Pro-atherosclerotic Low-density Neutrophils Are Present in Hypercholesterolemia', ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 38,
    Journal articles | 2018
    Hui TH; McClelland RL; Allison MA; Rodriguez CJ; Kronmal RA; Heckbert SR; Michos ED; Barter PJ; Rye KA; Ong KL, 2018, 'The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis', Atherosclerosis, 269, pp. 86 - 91,
    Journal articles | 2018
    Iborra RT; Machado-Lima A; Okuda LS; Pinto PR; Nakandakare ER; Machado UF; Correa-Giannella ML; Pickford R; Woods T; Brimble MA; Rye KA; Lu R; Yokoyama S; Passarelli M, 2018, 'AGE-albumin enhances ABCA1 degradation by ubiquitin-proteasome and lysosomal pathways in macrophages', Journal of Diabetes and its Complications, 32, pp. 1 - 10,
    Journal articles | 2018
    Kim WS; He Y; Phan K; Ahmed RM; Rye KA; Piguet O; Hodges JR; Halliday GM, 2018, 'Altered high density lipoprotein composition in behavioral variant frontotemporal dementia', Frontiers in Neuroscience, 12,
    Journal articles | 2018
    Ong KL; Morris MJ; McClelland RL; Hughes TM; Maniam J; Fitzpatrick AL; Martin SS; Luchsinger JA; Rapp SR; Hayden KM; Sandfort V; Allison MA; Rye KA, 2018, 'Relationship of Lipids and Lipid-Lowering Medications with Cognitive Function', American Journal of Epidemiology, 187, pp. 767 - 776,
    Journal articles | 2018
    Ong KL; Waters DD; Fayyad R; Vogt L; Melamed S; DeMicco DA; Rye KA; Barter PJ, 2018, 'Relationship of high-density lipoprotein cholesterol with renal function in patients treated with atorvastatin', Journal of the American Heart Association, 7, pp. e007387,
    Journal articles | 2018
    Perségol L; Darabi M; Dauteuille C; Lhomme M; Chantepie S; Rye KA; Therond P; Chapman MJ; Salvayre R; Nègre-Salvayre A; Lesnik P; Monier S; Kontush A, 2018, 'Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate', Journal of Lipid Research, 59, pp. 25 - 34,
    Journal articles | 2018
    Robinson JG; Williams KJ; Gidding S; Boršen J; Tabas I; Fisher EA; Packard C; Pencina M; Fayad ZA; Mani V; Rye KA; Nordestgaard BG; Tybjærg-Hansen A; Douglas PS; Nicholls SJ; Pagidipati N; Sniderman A, 2018, 'Eradicating the burden of atherosclerotic cardiovascular disease by lowering apolipoprotein b lipoproteins earlier in life', Journal of the American Heart Association, 7,
    Journal articles | 2018
    Rosenson RS; Brewer HB; Barter PJ; Björkegren JLM; Chapman MJ; Gaudet D; Kim DS; Niesor E; Rye KA; Sacks FM; Tardif JC; Hegele RA, 2018, 'HDL and atherosclerotic cardiovascular disease: Genetic insights into complex biology', Nature Reviews Cardiology, 15, pp. 9 - 19,
    Journal articles | 2018
    Shimabukuro Okuda L; Tallada Iborra R; Ramos Pinto P; Patel M; Fabres Machado U; Rye KA; Passarelli M, 2018, 'Advanced glycated apoaiv is less efficient in reducing inflammation in macrophages and unable to prevent the reduction in ABCA1 and ABCG1 Mrna induced by LPS', Atherosclerosis, 275, pp. e167 - e167,
    Journal articles | 2018
    Shrestha S; Wu BJ; Guiney L; Barter PJ; Rye KA, 2018, 'Cholesteryl ester transfer protein and its inhibitors', Journal of Lipid Research, 59, pp. 772 - 783,
    Journal articles | 2018
    Wewege MA; Thom JM; Rye KA; Parmenter BJ, 2018, 'Aerobic, resistance or combined training: A systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome', Atherosclerosis, 274, pp. 162 - 171,
    Journal articles | 2017
    Barter PJ; Rye KA, 2017, 'HDL cholesterol concentration or HDL function: Which matters?', European Heart Journal, 38, pp. 2487 - 2489,
    Journal articles | 2017
    Charlton F; Bobek G; Stait-Gardner T; Price WS; Colafella KMM; Xu B; Makris A; Rye KA; Hennessy A, 2017, 'The protective effect of apolipoprotein in models of trophoblast invasion and preeclampsia', American Journal of Physiology - Regulatory Integrative and Comparative Physiology, 312, pp. R40 - R48,
    Journal articles | 2017
    Chung RWS; Wang Z; Bursill CA; Wu BJ; Barter PJ; Rye KA; Wu B, 2017, 'Effect of long-term dietary sphingomyelin supplementation on atherosclerosis in mice', PLoS ONE, 12, pp. e0189523,
    Journal articles | 2017
    Cochran BJ; Hou L; Manavalan APC; Moore BM; Tabet F; Sultana A; Torres LC; Tang S; Shrestha S; Senanayake P; Patel M; Ryder WJ; Bongers A; Maraninchi M; Wasinger VC; Westerterp M; Tall AR; Barter PJ; Rye K-A, 2017, 'Impact of Perturbed Pancreatic beta-Cell Cholesterol 91˰涶ostasis on Adipose Tissue and Skeletal Muscle Metabolism (vol 65, pg 3610, 2016)', DIABETES, 66, pp. 560 - 560,
    Journal articles | 2017
    Cochran BJ; Ryder W; parmar A; Meikle S; Barter P; Rye K, 2017, 'Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT', Journal of Visualized Experiments,
    Journal articles | 2017
    Kokkinos J; Tang S; Rye KA; Ong KL, 2017, 'The role of fibroblast growth factor 21 in atherosclerosis', Atherosclerosis, 257, pp. 259 - 265,
    Journal articles | 2017
    Melchior JT; Walker RG; Cooke AL; Morris J; Castleberry M; Thompson TB; Jones MK; Song HD; Rye KA; Oda MN; Sorci-Thomas MG; Thomas MJ; Heinecke JW; Mei X; Atkinson D; Segrest JP; Lund-Katz S; Phillips MC; Davidson WS, 2017, 'A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state', Nature Structural and Molecular Biology, 24, pp. 1093 - 1099,
    Journal articles | 2017
    Ong KL; O'Connell R; Januszewski AS; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Scott RS; Taskinen MR; Waldman B; Colman PG; Best JD; Simes JR; Rye KA; Keech AC, 2017, 'Baseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD study', Clinical Chemistry, 63, pp. 1261 - 1270,
    Journal articles | 2017
    Pandzic E; Gelissen IC; Whan R; Barter PJ; Sviridov D; Gaus K; Rye KA; Cochran BJ, 2017, 'The ATP binding cassette transporter, ABCG1, localizes to cortical actin filaments', Scientific Reports, 7,
    Journal articles | 2017
    Stanton K; Kienzle V; Dinnes D; Jessup W; Kritharides L; Rye K; Celermajer D, 2017, 'Exercise During Military Training and Substantial Improvements in Cardiometabolic Health–The NSW Healthy Military Recruits Cardiometabolism (NHMRC) Study', Heart, Lung and Circulation, 26, pp. S115 - S116,
    Journal articles | 2017
    Van Der Vorst E; Theodorou K; Wu Y; Hoeksema M; Goossens P; Bursill C; Aliyev T; Tas S; Kuijpers M; Gijbels M; Schalkwijk C; Leitges M; Lawrence T; Touqui L; Plat J; Van Eck M; Rye K-A; De Winther M; Biessen E; Donners M, 2017, 'High density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-kB/STAT1-IRF1 signaling', Atherosclerosis, 263, pp. e6 - e6,
    Journal articles | 2017
    Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA, 2017, 'Reduction of in-stent restenosis by cholesteryl ester transfer protein inhibition', Arteriosclerosis, Thrombosis, and Vascular Biology, 37, pp. 2333 - 2341,
    Journal articles | 2017
    Zhang M; Lei D; Peng B; Yang M; Zhang L; Charles MA; Rye KA; Krauss RM; Johns DG; Ren G, 2017, 'Assessing the mechanisms of cholesteryl ester transfer protein inhibitors', Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1862, pp. 1606 - 1617,
    Journal articles | 2017
    da Silva KS; Pinto PR; Fabre NT; Gomes DJ; Thieme K; Okuda LS; Iborra RT; Freitas VG; Shimizu MHM; Teodoro WR; Marie SKN; Woods T; Brimble MA; Pickford R; Rye KA; Okamoto M; Catanozi S; Correa-Giannela ML; Machado UF; Passarelli M, 2017, 'N-acetylcysteine counteracts adipose tissue macrophage infiltration and insulin resistance elicited by advanced glycated albumin in healthy rats', Frontiers in Physiology, 8, pp. 723,
    Journal articles | 2017
    van der Vorst EPC; Theodorou K; Wu Y; Hoeksema MA; Goossens P; Bursill CA; Aliyev T; Huitema LFA; Tas SW; Wolfs IMJ; Kuijpers MJE; Gijbels MJ; Schalkwijk CG; Koonen DPY; Abdollahi-Roodsaz S; McDaniels K; Wang CC; Leitges M; Lawrence T; Plat J; Van Eck M; Rye KA; Touqui L; de Winther MPJ; Biessen EAL; Donners MMPC, 2017, 'High-Density Lipoproteins Exert Pro-inflammatory Effects on Macrophages via Passive Cholesterol Depletion and PKC-NF-κB/STAT1-IRF1 Signaling', Cell Metabolism, 25, pp. 197 - 207,
    Journal articles | 2016
    Anastasius M; Kockx M; Jessup W; Sullivan D; Rye KA; Kritharides L, 2016, 'Cholesterol efflux capacity: An introduction for clinicians', American Heart Journal, 180, pp. 54 - 63,
    Journal articles | 2016
    Barter PJ; Rye KA, 2016, 'Cholesteryl ester transfer protein inhibition is not yet dead - Pro', Arteriosclerosis, Thrombosis, and Vascular Biology, 36, pp. 439 - 441,
    Journal articles | 2016
    Barter PJ; Rye KA, 2016, 'Coronary artery disease: Scavenger receptor class B1-a target to reduce CHD risk?', Nature Reviews Cardiology, 13, pp. 249 - 250,
    Journal articles | 2016
    Barter PJ; Rye KA, 2016, 'New era of lipid-lowering drugs', Pharmacological Reviews, 68, pp. 458 - 475,
    Journal articles | 2016
    Cochran BJ; Hou L; Manavalan APC; Moore BM; Tabet F; Sultana A; Torres LC; Tang S; Shrestha S; Senanayake P; Patel M; Ryder WJ; Bongers A; Maraninchi M; Wasinger VC; Westerterp M; Tall AR; Barter PJ; Rye KA, 2016, 'Impact of perturbed pancreatic β-cell cholesterol homeostasis on adipose tissue and skeletal muscle metabolism', Diabetes, 65, pp. 3610 - 3620,
    Journal articles | 2016
    Cochran BJ; Ryder WJ; Parmar A; Tang S; Reilhac A; Arthur A; Charil A; Hamze H; Barter PJ; Kritharides L; Meikle SR; Gregoire MC; Rye KA, 2016, 'In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes', Diabetologia, 59, pp. 1977 - 1984,
    Journal articles | 2016
    Darabi M; Tubeuf E; Lhomme M; Guillas-Baudouin I; Dauteuille C; Patel M; Huby T; Gautier EL; Rye KA; Lesnik P; Le Goff W; Kontush A, 2016, 'Phosphatidylserine improves anti-inflammatory function of reconstituted HDL in macrophages via SR-BI-, Akt- and p38 MAPK-dependent pathways', Atherosclerosis, 252, pp. e242 - e242,
    Journal articles | 2016
    Dinnes DLM; White MY; Kockx M; Traini M; Hsieh V; Kim MJ; Hou L; Jessup W; Rye KA; Thaysen-Andersen M; Cordwell SJ; Kritharides L, 2016, 'Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity', FASEB Journal, 30, pp. 4239 - 4255,
    Journal articles | 2016
    Geronimo FRB; Barter PJ; Rye KA; Heather AK; Shearston KD; Rodgers KJ, 2016, 'Plaque stabilizing effects of apolipoprotein A-IV', Atherosclerosis, 251, pp. 39 - 46,
    Journal articles | 2016
    Gomes DJ; Velosa AP; Okuda LS; Fusco FB; da Silva KS; Pinto PR; Nakandakare ER; Correa-Giannella ML; Woods T; Brimble MA; Pickford R; Rye KA; Teodoro WR; Catanozi S; Passarelli M, 2016, 'Glycated albumin induces lipid infiltration in mice aorta independently of DM and RAS local modulation by inducing lipid peroxidation and inflammation', Journal of Diabetes and its Complications, 30, pp. 1614 - 1621,
    Journal articles | 2016
    Julovi SM; Xue A; Thanh Le TN; Gill AJ; Bulanadi JC; Patel M; Waddington LJ; Rye KA; Moghaddam MJ; Smith RC, 2016, 'Apolipoprotein A-II plus lipid emulsion enhance cell growth via SR-B1 and target pancreatic cancer in vitro and in vivo', PLoS ONE, 11,
    Journal articles | 2016
    Kockx M; Glaros E; Leung B; Ng TW; Berbée JFP; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PCN; Meikle PJ; Kritharides L, 2016, 'Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia', Arteriosclerosis, Thrombosis, and Vascular Biology, 36, pp. 1338 - 1349,
    Journal articles | 2016
    Kritharides L; Rye KA; Lambert TJ; Jessup W, 2016, 'Lipidology, cardiovascular risk, and schizophrenia', Current Opinion in Lipidology, 27, pp. 305 - 307,
    Journal articles | 2016
    Ong KL; Morris MJ; McClelland RL; Maniam J; Allison MA; Rye KA, 2016, 'Lipids, lipoprotein distribution and depressive symptoms: The multi-ethnic study of atherosclerosis', Translational Psychiatry, 6, pp. e962 - e962,
    Journal articles | 2016
    Puranik R; Bao S; Bonin AM; Kaur R; Weder JE; Casbolt L; Hambley TW; Lay PA; Barter PJ; Rye KA, 2016, 'A novel class of copper(II)- and zinc(II)-bound non-steroidal anti-inflammatory drugs that inhibits acute inflammation in vivo', Cell and Bioscience, 6,
    Journal articles | 2016
    Rye KA; Barter PJ; Cochran BJ, 2016, 'Apolipoprotein A-I interactions with insulin secretion and production', Current Opinion in Lipidology, 27, pp. 8 - 13,
    Journal articles | 2016
    Shrestha S; Jessup W; Tabet F; Barter PJ; Rye K-A, 2016, 'Abstract 196: Impact of Cholesteryl Ester Transfer Protein Inhibition With TA-8995 on High Density Lipoprotein Function', Arteriosclerosis, Thrombosis, and Vascular Biology, 36,
    Journal articles | 2016
    Siebel AL; Trinh SK; Formosa MF; Mundra PA; Natoli AK; Reddy-Luthmoodoo M; Huynh K; Khan AA; Carey AL; Van Hall G; Cobelli C; Dalla-Man C; Otvos JD; Rye KA; Johansson J; Gordon A; Wong NCW; Sviridov D; Barter P; Duffy SJ; Meikle PJ; Kingwell BA, 2016, 'Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial', Metabolism: Clinical and Experimental, 65, pp. 904 - 914,
    Journal articles | 2016
    Sultana A; Cochran BJ; Tabet F; Patel M; Cuesta Torres L; Barter PJ; Rye K, 2016, 'Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I', The FASEB Journal
    Journal articles | 2016
    Tabet F; Torres LFC; Ong KL; Shrestha S; Choteau SA; Barter PJ; Clifton P; Rye KA, 2016, 'High-density lipoprotein-associated miR-223 is altered after diet-induced weight loss in overweight and obese males', PLoS ONE, 11,
    Journal articles | 2016
    Van der Vorst EPC; Theodorou K; Hoeksema MA; Wu Y; Goossens P; Van Eck M; Rye K-A; De Winther MPJ; Biessen EAL; Donners MMP, 2016, 'High density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-kB/STAT1-IRF1 signaling', CARDIOVASCULAR RESEARCH, 111, pp. S10 - S10,
    Journal articles | 2016
    van der Vorst E; Theodorou K; Wu Y; Hoeksema M; Goossens P; Bursill C; Huitema L; Tas S; Gijbels M; McDaniels K; Wang CC; Leitges M; Lawrence T; Touqui L; Plat J; van Eck M; Rye KA; de Winther M; Biessen E; Donners M, 2016, 'LIPOPROTEINS AND LIPID METABOLISM: HDL. HIGH DENSITY LIPOPROTEINS EXERT PRO-INFLAMMATORY EFFECTS ON MACROPHAGES VIA PASSIVE CHOLESTEROL DEPLETION AND PKC-NF-KB/STAT1-IRF1 SIGNALING', ATHEROSCLEROSIS, 252, pp. E108 - E109,
    Journal articles | 2015
    Barter PJ; Nicholls SJ; Kastelein JJP; Rye KA, 2015, 'Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk?: CETP inhibition as a strategy to reduce cardiovascular risk: The pro case', Circulation, 132, pp. 423 - 432,
    Journal articles | 2015
    Barter PJ; Rye KA, 2015, 'Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?', Clinical Therapeutics, 37, pp. 2716 - 2731,
    Journal articles | 2015
    Barter PJ; Tabet F; Rye KA, 2015, 'Reduction in PCSK9 levels induced by anacetrapib: an off-target effect?', Journal of lipid research, 56, pp. 2045 - 2047,
    Journal articles | 2015
    Besseling J; Ong KL; Huijgen R; Rye KA; Hovingh GK; Hutten BA; Lambert G, 2015, 'The impact of LDLR function on fibroblast growth factor 21 levels', Atherosclerosis, 241, pp. 322 - 325,
    Journal articles | 2015
    Bisoendial R; Tabet F; Tak PP; Petrides F; Torres LFC; Hou L; Cook A; Barter PJ; Weninger W; Rye KA, 2015, 'Apolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on Lymphangiogenesis', Arteriosclerosis, Thrombosis, and Vascular Biology, 35, pp. 2443 - 2450,
    Journal articles | 2015
    Di Bartolo BA; Cartland SP; Vellozzi M; Rye K-A; Kavurma MM, 2015, 'Abstract 103: HDL Improves Cholesterol and Glucose 91˰涶ostasis and Reduces Atherosclerosis in TRAIL-/-ApoE-/- mice', Arteriosclerosis, Thrombosis, and Vascular Biology, 35,
    Journal articles | 2015
    Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W, 2015, 'HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export', Circulation Research, 116, pp. 1133 - 1142,
    Journal articles | 2015
    Ong KL; Ding J; McClelland RL; Cheung BMY; Criqui MH; Barter PJ; Rye KA; Allison MA, 2015, 'Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis', Atherosclerosis, 239, pp. 386 - 392,
    Journal articles | 2015
    Ong KL; Ding J; McClelland RL; Cheung BMY; Criqui MH; Barter PJ; Rye KA; Allison MA, 2015, 'Relationship of pericardial fat with lipoprotein distribution: The Multi-Ethnic study of atherosclerosis', Atherosclerosis, 241, pp. 664 - 670,
    Journal articles | 2015
    Ong KL; Januszewski AS; O’Connell R; Buizen L; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Scott RS; Taskinen MR; Rye KA; Keech AC, 2015, 'Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study', Diabetologia, 58, pp. 2035 - 2044,
    Journal articles | 2015
    Ong KL; Januszewski AS; O’Connell R; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Hung WT; Scott RS; Taskinen MR; Keech AC; Rye KA, 2015, 'The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study', Diabetologia, 58, pp. 464 - 473,
    Journal articles | 2015
    Rye KA; Barter PJ; Brown AJ, 2015, 'Speed kills in more ways than one: Methamphetamine and atherosclerosis', Atherosclerosis, 243, pp. 654 - 655,
    Journal articles | 2015
    Rye KA; Ong KL, 2015, 'HDL function as a predictor of coronary heart disease events: Time to re-assess the HDL hypothesis?', The Lancet Diabetes and Endocrinology, 3, pp. 488 - 489,
    Journal articles | 2015
    Tabet F; Cuesta Torres LF; Wiese CB; Öhrling G; Larsson R; Barter PJ; Vickers KC; Rye K-A, 2015, 'Abstract 47: High-Density Lipoproteins Induce Neutrophil-miRNA Transcription and Export: Contribution to HDL-miRNA Cell to Cell Communication', Arteriosclerosis, Thrombosis, and Vascular Biology, 35,
    Journal articles | 2015
    Wu BJ; Shrestha S; Ong KL; Johns D; Dunn LL; Hou L; Barter PJ; Rye KA, 2015, 'Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis', International Journal of Cardiology, 199, pp. 204 - 212,
    Journal articles | 2015
    Wu BJ; Shrestha S; Ong KL; Johns D; Hou L; Barter PJ; Rye KA, 2015, 'Cholesteryl Ester Transfer Protein Inhibition Enhances Endothelial Repair and Improves Endothelial Function in the Rabbit', Arteriosclerosis, Thrombosis, and Vascular Biology, 35, pp. 628 - 636,
    Journal articles | 2015
    Zhang M; Charles R; Tong H; Zhang L; Patel M; Wang F; Rames MJ; Ren A; Rye KA; Qiu X; Johns DG; Charles MA; Ren G, 2015, 'HDL surface lipids mediate CETP binding as revealed by electron microscopy and molecular dynamics simulation', Scientific Reports, 5,
    Journal articles | 2014
    Charlton F; Tooher J; Rye KA; Hennessy A, 2014, 'Cardiovascular risk, lipids and pregnancy: Preeclampsia and the risk of later life cardiovascular disease', Heart Lung and Circulation, 23, pp. 203 - 212,
    Journal articles | 2014
    Cochran BJ; Bisoendial RJ; Hou L; Glaros E; Rossy J; Thomas SR; Barter PJ; Rye KA, 2014, 'Apolipoprotein a-I increases insulin secretion and production from pancreatic β-cells via a g-protein-camp-PKA-FOXO1-dependent mechanism', Arteriosclerosis, Thrombosis, and Vascular Biology,
    Journal articles | 2014
    Lambert G; Chatelais M; Petrides F; Passard M; Thedrez A; Rye KA; Schwahn U; Gusarova V; Blom DJ; Sasiela W; Marais AD, 2014, 'Normalization of low-density lipoprotein receptor expression in receptor defective homozygous familial hypercholesterolemia by inhibition of PCSK9 with alirocumab', Journal of the American College of Cardiology, 64, pp. 2299 - 2300,
    Journal articles | 2014
    Lambert G; Petrides F; Chatelais M; Blom DJ; Choque B; Tabet F; Wong G; Rye KA; Hooper AJ; Burnett JR; Barter PJ; Marais AD, 2014, 'Elevated plasma PCSK9 level is equally detrimental for patients with nonfamilial hypercholesterolemia and heterozygous familial hypercholesterolemia, irrespective of low-density lipoprotein receptor defects', Journal of the American College of Cardiology, 63, pp. 2365 - 2373,
    Journal articles | 2014
    McGrath KC; Li XH; Whitworth PT; Kasz R; Tan JT; McLennan SV; Celermajer DS; Barter PJ; Rye KA; Heather AK, 2014, 'High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation', Journal of Lipid Research, 55, pp. 421 - 430,
    Journal articles | 2014
    Ong KL; Allison MA; Cheung BMY; Wu BJ; Barter PJ; Rye KA; Wu B, 2014, 'The relationship between total Bilirubin levels and total mortality in older adults: The United States national health and nutrition examination survey (NHANES) 1999-2004', PLoS ONE, 9, pp. e94479,
    Journal articles | 2014
    Ong KL; McClelland RL; Rye KA; Cheung BMY; Post WS; Vaidya D; Criqui MH; Cushman M; Barter PJ; Allison MA, 2014, 'The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: The multi-ethnic study of atherosclerosis', Atherosclerosis, 236, pp. 257 - 262,
    Journal articles | 2014
    Ong KL; Waters DD; Messig M; Demicco DA; Rye KA; Barter PJ, 2014, 'Effect of change in body weight on incident diabetes mellitus in patients with stable coronary artery disease treated with atorvastatin (from the Treating to New Targets Study)', American Journal of Cardiology, 113, pp. 1593 - 1598,
    Journal articles | 2014
    Rye KA; Barter PJ, 2014, 'Regulation of high-density lipoprotein metabolism', Circulation Research, 114, pp. 143 - 156,
    Journal articles | 2014
    Rye KA; Barter PJ, 2014, 'Thematic review series: High density lipoprotein structure, function, and metabolism cardioprotective functions of HDLs 1', Journal of Lipid Research, 55, pp. 168 - 179,
    Journal articles | 2014
    Rye KA, 2014, 'Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease', Clinical and Experimental Nephrology, 18, pp. 247 - 250,
    Journal articles | 2014
    Tabet F; Lee S; Cuesta Torres LF; Levin MG; Drummond GR; Remaley AT; Rye K-A; Sobey CG; Vickers KC, 2014, 'Abstract 312: Transcriptional and Posttranscriptional Circuitry in the Brain After Transient and Permanent Ischemia', Arteriosclerosis, Thrombosis, and Vascular Biology, 34,
    Journal articles | 2014
    Tabet F; Vickers KC; Cuesta Torres LF; Ammori B; Yadav R; Hama S; Liu Y; Schofield J; Barter P; Soran H; Rye K-A, 2014, 'Abstract 612: Effect of Bariatric Surgery on HDL-Associated MicroRNAs', Arteriosclerosis, Thrombosis, and Vascular Biology, 34,
    Journal articles | 2014
    Tabet F; Vickers KC; Cuesta Torres LF; Wiese CB; Shoucri BM; Lambert G; Catherinet C; Prado-Lourenco L; Levin MG; Thacker S; Sethupathy P; Barter PJ; Remaley AT; Rye KA, 2014, 'HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells', Nature Communications, 5,
    Journal articles | 2014
    Vickers KC; Landstreet SR; Levin MG; Shoucri BM; Toth CL; Taylor RC; Palmisano BT; Tabet F; Cui HL; Rye KA; Sethupathy P; Remaley AT, 2014, 'MicroRNA-223 coordinates cholesterol homeostasis', Proceedings of the National Academy of Sciences of the United States of America, 111, pp. 14518 - 14523,
    Journal articles | 2014
    Vickers KC; Rye KA; Tabet F, 2014, 'MicroRNAs in the onset and development of cardiovascular disease', Clinical Science, 126, pp. 183 - 194,
    Journal articles | 2014
    Wiese CB; Toth CL; Tabet F; Taylor RC; Landstreet SR; Rye K-A; Hofmeister LH; Harrison DG; Kon V; Vickers KC, 2014, 'Abstract 3: HDL-MicroRNA-92a and Interleukin-33 Axis Underlies Endothelial Dysfunction Associated With Atherosclerosis and Chronic Kidney Disease', Arteriosclerosis, Thrombosis, and Vascular Biology, 34,
    Journal articles | 2014
    Wu BJ; Ong KL; Shrestha S; Chen K; Tabet F; Barter PJ; Rye KA, 2014, 'Inhibition of arthritis in the lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins', Arteriosclerosis, Thrombosis, and Vascular Biology, 34, pp. 543 - 551,
    Journal articles | 2013
    Bisoendial R; Roediger B; Jain R; Cavanagh L; Tak P-P; Rye K-A; Weninger W, 2013, 'THU0096 Targeting Lymphatic Dysfunction in Rheumatoid Arthritis by High-Density Lipoprotein', Annals of the Rheumatic Diseases, 72, pp. A195.2 - A195,
    Journal articles | 2013
    Brown BE; Nobecourt E; Zeng J; Jenkins AJ; Rye KA; Davies MJ, 2013, 'Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages', PLoS ONE, 8,
    Journal articles | 2013
    Chung RWS; Kamili A; Tandy S; Weir JM; Gaire R; Wong G; Meikle PJ; Cohn JS; Rye KA, 2013, 'Dietary Sphingomyelin Lowers Hepatic Lipid Levels and Inhibits Intestinal Cholesterol Absorption in High-Fat-Fed Mice', PLoS ONE, 8,
    Journal articles | 2013
    Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL, 2013, 'Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: Comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl)', Biochemical Journal, 449, pp. 531 - 542,
    Journal articles | 2013
    Huijgen R; Boekholdt SM; Arsenault BJ; Bao W; Davaine JM; Tabet F; Petrides F; Rye KA; DeMicco DA; Barter PJ; Kastelein JJP; Lambert G, 2013, 'Erratum: Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) Trial (Journal of the American College of Cardiology (2012) 59 (1778-1784))', Journal of the American College of Cardiology, 61, pp. 1751,
    Journal articles | 2013
    Mulay V; Wood P; Manetsch M; Darabi M; Cairns R; Hoque M; Chan KC; Reverter M; Álvarez-Guaita A; Rye KA; Rentero C; Heeren J; Enrich C; Grewal T, 2013, 'Inhibition of Mitogen-Activated Protein Kinase Erk1/2 Promotes Protein Degradation of ATP Binding Cassette Transporters A1 and G1 in CHO and HuH7 Cells', PLoS ONE, 8,
    Journal articles | 2013
    Ong KL; Allison MA; Cheung BMY; Wu BJ; Barter PJ; Rye KA; Wu B, 2013, 'Trends in C-reactive protein levels in US adults from 1999 to 2010', American Journal of Epidemiology, 177, pp. 1430 - 1442,
    Journal articles | 2013
    Ong KL; Wu BJ; Cheung BMY; Barter PJ; Rye KA; Wu B, 2013, 'Arthritis: Its prevalence, Risk factors, And association with cardiovascular diseases in the United States, 1999 to 2008', Annals of Epidemiology, 23, pp. 80 - 86,
    Journal articles | 2013
    Rye KA, 2013, 'High density lipoprotein structure, function, and metabolism: A new Thematic Series', Journal of Lipid Research, 54, pp. 2031 - 2033,
    Journal articles | 2013
    Tso C; Rye K; Barter P, 2013, 'Effects of Low-Density Lipoproteins on Endothelium-Generation from Human Peripheral Blood Mononuclear Cells', Heart, Lung and Circulation, 22, pp. S16 - S16,
    Journal articles | 2013
    Van Der Vorst EPC; Vanags LZ; Dunn LL; Prosser HC; Rye KA; Bursill CA, 2013, 'High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells', FASEB Journal, 27, pp. 1413 - 1425,
    Journal articles | 2013
    Wu BJ; Chen K; Shrestha S; Ong KL; Barter PJ; Rye KA, 2013, 'High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-[INCREMENT]24 reductase expression and inducing heme oxygenase-1', Circulation Research, 112, pp. 278 - 288,
    Journal articles | 2013
    Wu BJ; Ong KL; Shrestha S; Chen K; Barter PJ; Rye K-A, 2013, 'Abstract 3: Apolipoprotein A-I Inhibits Streptococcal Cell Wall-Induced Arthritis in the Rat in an ABCA1-dependent Manner', Arteriosclerosis, Thrombosis, and Vascular Biology, 33,
    Journal articles | 2013
    Yu S; Youssef P; Tabet F; Rye K; Bisoendial R, 2013, 'HIGH DENSITY LIPOPROTEIN FUNCTION IN RHEUMATOID ARTHRITIS BEFORE AND AFTER TNF alpha INHIBITION', INTERNAL MEDICINE JOURNAL, 43, pp. 9 - 9,
    Journal articles | 2012
    Barter PJ; Rye KA; Beltangady MS; Ports WC; Duggan WT; Boekholdt SM; DeMicco DA; Kastelein JJP; Shear CL, 2012, 'Relationship between atorvastatin dose and the harm caused by torcetrapib', Journal of Lipid Research, 53, pp. 2436 - 2442,
    Journal articles | 2012
    Barter PJ; Rye KA, 2012, 'Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk', Journal of Lipid Research, 53, pp. 1755 - 1766,
    Journal articles | 2012
    Bisoendial R; Weninger W; Petrides F; Tabet F; Tak PP; Rye KA, 2012, 'Abstract 305: HDL Antagonizes the Defects in the Lymphatic System that Contribute to the Pathogenesis of Rheumatoid Arthritis', Arteriosclerosis, Thrombosis, and Vascular Biology, 32,
    Journal articles | 2012
    Borthwick F; Warnakula S; Mangat R; Uwiera RR; Russell JC; Kelly SE; Lee CY; Hryshko L; Mamo JCL; Rye KA; Lopaschuk GD; Proctor SD, 2012, 'ApoA-1 infusion reduces arterial cholesterol and myocardial lesions in a rat model of cardiac dysfunction and insulin resistance', Atherosclerosis, 222, pp. 402 - 408,
    Journal articles | 2012
    Cakan Y; Tabet F; Lau E; Celermajer DS; Barter PJ; Rye K-A, 2012, 'Abstract 106: Corticosteroid Treatment Induces Structural and Functional Changes in High-Density Lipoproteins', Arteriosclerosis, Thrombosis, and Vascular Biology, 32,
    Journal articles | 2012
    Charlton F; Xu B; Makris A; Hennessy A; Rye K-A, 2012, 'OS041. Apolipoprotein A-I protects normal integration of the trophoblast into endothelial cellular networks in an in vitro model of preeclampsia.', Pregnancy Hypertens, 2, pp. 198 - 199,
    Journal articles | 2012
    Charlton F; Xu B; Makris A; Rye K-A; Hennessy A, 2012, '977 HIGH DENSITY LIPOPROTEIN (HDL) AND ITS COMPONENTS protect normal integration of the trophoblast into endothelial cellular networks in an in vitro model of Preeclampsia', Journal of Hypertension, 30, pp. e277 - e277,
    Journal articles | 2012
    Charlton F; Xu B; Makris A; Rye K-A; Hennessy A, 2012, '978 Molecular changes underlying apolipoprotein (apo)A-I protection of normal integration of the trophoblast into endothelial cellular networks in an in vitro model of preeclampsia', Journal of Hypertension, 30, pp. e282 - e283,
    Journal articles | 2012
    Cochran BJ; Rye K-A, 2012, 'Abstract 34: Apolipoprotein A-I Increases Insulin Secretion from β-cells via a Protein Kinase A Dependent Mechanism', Arteriosclerosis, Thrombosis, and Vascular Biology, 32,
    Journal articles | 2012
    Drew BG; Rye KA; Duffy SJ; Barter P; Kingwell BA, 2012, 'The emerging role of HDL in glucose metabolism', Nature Reviews Endocrinology, 8, pp. 237 - 245,
    Journal articles | 2012
    Gao X; Gu H; Li G; Rye KA; Zhang DW, 2012, 'Identification of an amino acid residue in ATP-binding cassette transport G1 critical for mediating cholesterol efflux', Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1821, pp. 552 - 559,
    Journal articles | 2012
    Huijgen R; Boekholdt SM; Arsenault BJ; Bao W; Davaine JM; Tabet F; Petrides F; Rye KA; Demicco DA; Barter PJ; Kastelein JJP; Lambert G, 2012, 'Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: A nested case-control study', Journal of the American College of Cardiology, 59, pp. 1778 - 1784,
    Journal articles | 2012
    Ismael F; Hadfield KA; Pattison DI; Rye KA; Davies MJ; Hawkins CL, 2012, 'Role of lipoprotein modification by the myeloperoxidase-derived oxidant HOSCN in the formation of foam cells in atherosclerosis', FREE RADICAL BIOLOGY AND MEDICINE, 53, pp. S130 - S131,
    Journal articles | 2012
    Ong KL; Rye KA; O'Connell R; Jenkins AJ; Brown C; Xu A; Sullivan DR; Barter PJ; Keech AC, 2012, 'Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes', Journal of Clinical Endocrinology and Metabolism, 97, pp. 4701 - 4708,
    Journal articles | 2012
    Ren G; Zhang L; Yan F; Zhang S; Lei D; Charles MA; Cavigiolio G; Oda M; Krauss RM; Weisgraber KH; Rye K-A; Pownall HJ; Qiu X, 2012, 'Abstract 46: Cholesteryl Ester Transfer Protein Interactions with Lipoproteins: Insights into Mechanisms by Electron Microscopy and Molecular Dynamics Simulation', Arteriosclerosis, Thrombosis, and Vascular Biology, 32,
    Journal articles | 2012
    Rye KA; Barter PJ, 2012, 'Predictive value of different HDL particles for the protection against or risk of coronary heart disease', Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1821, pp. 473 - 480,
    Journal articles | 2012
    Rye KA; Barter PJ, 2012, 'The inhibition of cholesteryl ester transfer protein: A long and winding road', Journal of Lipid Research, 53, pp. 1039 - 1041,
    Journal articles | 2012
    Tso C; Rye K; Barter P, 2012, 'The Effects of ApoA-I, A-II and A-IV on Endothelium-generation from Human Peripheral Blood Mononuclear Cells', Heart, Lung and Circulation, 21, pp. S24 - S24,
    Journal articles | 2012
    Tso C; Rye KA; Barter P, 2012, 'Phenotypic and functional changes in blood monocytes following adherence to endothelium', PLoS ONE, 7,
    Journal articles | 2012
    Wu BJ; Chen K; Barter PJ; Rye KA, 2012, 'Niacin inhibits vascular inflammation via the induction of heme oxygenase-1', Circulation, 125, pp. 150 - 158,
    Journal articles | 2012
    Zhang L; Yan F; Zhang S; Lei D; Charles MA; Cavigiolio G; Oda M; Krauss RM; Weisgraber KH; Rye KA; Pownall HJ; Qiu X; Ren G, 2012, 'Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein', Nature Chemical Biology, 8, pp. 342 - 349,
    Journal articles | 2011
    Barter P; Rye KA, 2011, 'Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: Where are we now?', Trends in Pharmacological Sciences, 32, pp. 694 - 699,
    Journal articles | 2011
    Barter PJ; Rye KA; Tardif JC; Waters DD; Matthijs BS; Breazna A; Kastelein JJP, 2011, 'Effect of torcetrapib on glucose, insulin, and hemoglobin a1c in subjects in the investigation of lipid level management to understand its impact in atherosclerotic events (Illuminate) Trial', Circulation, 124, pp. 555 - 562,
    Journal articles | 2011
    Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C, 2011, 'The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins', Atherosclerosis, 217, pp. 395 - 400,
    Journal articles | 2011
    Di Bartolo BA; Vanags LZ; Tan JT; Bao S; Rye KA; Barter PJ; Bursill CA, 2011, 'The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit.', Lipids in health and disease, 10, pp. 224,
    Journal articles | 2011
    Elliott DA; Tsoi K; Holinkova S; Chan LL; Kim WS; Halliday GM; Rye K; Garner B, 2011, 'Isoform-specific proteolysis of apolipoprotein-E in the brain', Neurobiology of Aging, 32, pp. 257 - 271,
    Journal articles | 2011
    Hadfield KA; Pattison DI; Rye K-A; Davies MJ; Hawkins CL, 2011, 'Oxidation of Lipid-Free Apolipoprotein A-I by Thiocyanate-Derived Oxidants Compromises its Ability To Efflux Cholesterol', Free Radical Biology and Medicine, 51, pp. S41 - S41,
    Journal articles | 2011
    Kitajima K; Miura SI; Yamauchi T; Uehara Y; Kiya Y; Rye KA; Kadowaki T; Saku K, 2011, 'Possibility of increasing cholesterol efflux by adiponectin and its receptors through the ATP binding cassette transporter A1 in HEK293T cells', Biochemical and Biophysical Research Communications, 411, pp. 305 - 311,
    Journal articles | 2011
    Ong KL; Barter PJ; Rye KA, 2011, 'Response to statin use and serum bilirubin levels', Atherosclerosis, 219, pp. 392,
    Journal articles | 2011
    Ong KL; Tso AWK; Xu A; Law LSC; Li M; Wat NMS; Rye KA; Lam TH; Cheung BMY; Lam KSL, 2011, 'Evaluation of the combined use of adiponectin and C-reactive protein levels as biomarkers for predicting the deterioration in glycaemia after a median of 5.4 years', Diabetologia, 54, pp. 2552 - 2560,
    Journal articles | 2011
    Ong KL; Wu BJ; Cheung BMY; Barter PJ; Rye KA, 2011, 'Association of lower total bilirubin level with statin usage: The United States National Health and Nutrition Examination Survey 1999-2008', Atherosclerosis, 219, pp. 728 - 733,
    Journal articles | 2011
    Reimers GJ; Jackson CL; Rickards J; Chan PY; Cohn JS; Rye KA; Barter PJ; Rodgers KJ, 2011, 'Inhibition of rupture of established atherosclerotic plaques by treatment with apolipoprotein A-I', Cardiovascular Research, 91, pp. 37 - 44,
    Journal articles | 2011
    Tabet F; Lambert G; Cuesta Torres LF; Hou L; Sotirchos I; Touyz RM; Jenkins AJ; Barter PJ; Rye KA, 2011, 'Lipid-free apolipoprotein A-I and discoidal reconstituted high-density lipoproteins differentially inhibit glucose-induced oxidative stress in human macrophages', Arteriosclerosis, Thrombosis, and Vascular Biology, 31, pp. 1192 - 1200,
    Journal articles | 2011
    Tso C; Rye K; Barter P, 2011, 'Lipid-free Apolipoprotein A-I Enhances Endothelium generation from Human Blood Monocytes', Heart, Lung and Circulation, 20, pp. S15 - S15,
    Journal articles | 2011
    Wood P; Mulay V; Darabi M; Chan KC; Heeren J; Pol A; Lambert G; Rye KA; Enrich C; Grewal T, 2011, 'Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI', Journal of Biological Chemistry, 286, pp. 23077 - 23092,
    Journal articles | 2011
    Wu Z; Gogonea V; Lee X; May RP; Pipich V; Wagner MA; Undurti A; Tallant TC; Baleanu-Gogonea C; Charlton F; Ioffe A; DiDonato JA; Rye KA; Hazen SL, 2011, 'The low resolution structure of ApoA1 in spherical high density lipoprotein revealed by small angle neutron scattering', Journal of Biological Chemistry, 286, pp. 12495 - 12508,
    Journal articles | 2011
    Zhang L; Song J; Cavigiolio G; Ishida BY; Zhang S; Kane JP; Weisgraber KH; Oda MN; Rye KA; Pownall HJ; Ren G, 2011, 'Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy', Journal of Lipid Research, 52, pp. 175 - 184,
    Journal articles | 2010
    Bursill CA; Castro ML; Beattie DT; Nakhla S; Van Der Vorst E; Heather AK; Barter PJ; Rye KA, 2010, 'High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo', Arteriosclerosis, Thrombosis, and Vascular Biology, 30, pp. 1773 - 1778,
    Journal articles | 2010
    Chan DC; Hamilton SJ; Rye KA; Chew GT; Jenkins AJ; Lambert G; Watts GF, 2010, 'Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients', Diabetes, Obesity and Metabolism, 12, pp. 752 - 756,
    Journal articles | 2010
    Charlton F; Xu B; Makris A; Rye K-A; Hennessy A, 2010, 'T9.4 High density lipoproteins protect against TNF-alpha induced inhibition of trophoblast/tubular endothelial cell integration', Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health, 1, pp. S19 - S19,
    Journal articles | 2010
    Fryirs MA; Barter P; Appavoo M; Tuch BE; Tabet F; Heather AK; Rye K, 2010, 'Effects of High-Density Lipoproteins on Pancreatic -Cell Insulin Secretion', Arteriosclerosis, Thrombosis and Vascular Biology, 30, pp. 1642 - 1648
    Journal articles | 2010
    Imaizumi S; Kiya Y; Miura SI; Zhang B; Matsuo Y; Uehara Y; Rye KA; Saku K, 2010, 'Pharmacological intervention using reconstituted high-density lipoprotein changes in the lipid profile in spontaneously hypersensitive rats', Clinical and Experimental Hypertension, 32, pp. 202 - 208,
    Journal articles | 2010
    Nobécourt E; Tabet F; Lambert G; Puranik R; Bao S; Yan L; Davies MJ; Brown BE; Jenkins AJ; Dusting GJ; Bonnet DJ; Curtiss LK; Barter PJ; Rye KA, 2010, 'Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I', Arteriosclerosis, Thrombosis, and Vascular Biology, 30, pp. 766 - 772,
    Journal articles | 2010
    Patel S; Di bartolo B; Nakhla S; Heather A; Mitchell T; Jessup W; Celermajer D; Barter P; Rye K, 2010, 'Anti-inflammatory effects of apolipoprotein A-I in the rabbit', Atherosclerosis, 212, pp. 392 - 397
    Journal articles | 2010
    Ren G; Zhang S; Cavigiolio G; Lei D; Oda M; Weisgraber KH; Rye K-A; Pownall HJ; Qiu X, 2010, 'Cholesteryl Ester Transfer Protein Penetrates Lipoproteins For Cholesteryl Ester Transfer', Biophysical Journal, 98, pp. 36a - 36a,
    Journal articles | 2010
    Tabet F; Remaley AT; Segaliny AI; Millet J; Yan L; Nakhla S; Barter PJ; Rye KA; Lambert G, 2010, 'The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro', Arteriosclerosis, Thrombosis, and Vascular Biology, 30, pp. 246 - 252,
    Journal articles | 2010
    Tso C; Rye K; Barter P, 2010, 'Generation of Endothelial-like Cells from Endothelium-adherent Blood Monocytes', Heart, Lung and Circulation, 19, pp. S14 - S14,
    Journal articles | 2010
    Wu BJ; Yan L; Charlton F; Witting P; Barter PJ; Rye KA, 2010, 'Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids', Arteriosclerosis, Thrombosis, and Vascular Biology, 30, pp. 968 - 975,
    Journal articles | 2010
    Zhang L; Cavigiolio G; Oda M; Rye K-A; Ren G, 2010, 'A Method to Study the Time-Dependent Remodeling of High Density Lipoproteins by Individual-Particle Electron Cryo-Tomography', Biophysical Journal, 98, pp. 440a - 440a,
    Journal articles | 2010
    Zhang L; Cavigiolio G; Wang J; Rye K-A; Oda M; Ren G, 2010, 'Structure of 9.6nm Discoidal High-Density Lipoprotein Revealed by Individual-Particle Electron Tomography', Biophysical Journal, 98, pp. 440a - 440a,
    Journal articles | 2010
    de Souza JA; Vindis C; Nègre-Salvayre A; Rye KA; Couturier M; Therond P; Chantepie S; Salvayre R; Chapman MJ; Kontush A, 2010, 'Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: Pivotal role of apolipoprotein A-I', Journal of Cellular and Molecular Medicine, 14, pp. 608 - 620,
    Journal articles | 2009
    Bursill C; Castro L; Barter P; Rye K, 2009, 'Abstract: 1095 HIGH DENSITY LIPOPROTEINS (HDL) REDUCE THE EXPRESSION OF CHEMOKINE RECEPTORS CCR2 AND CX3CR1 IN MONOCYTES', Atherosclerosis Supplements, 10, pp. e432 - e432,
    Journal articles | 2009
    Bursill C; Castro L; Barter P; Rye K, 2009, 'Abstract: P1151 HIGH DENSITY LIPOPROTEINS (HDL) REDUCE CHEMOKINE EXPRESSION IN MONOCYTES AND ENDOTHELIAL CELLS', Atherosclerosis Supplements, 10, pp. e1177 - e1177,
    Journal articles | 2009
    Chan DC; Lambert G; Barrett PHR; Rye KA; Ooi EMM; Watts GF, 2009, 'Plasma proprotein convertase subtilisin/kexin type 9: A marker of LDL apolipoprotein B-100 catabolism?', Clinical Chemistry, 55, pp. 2049 - 2052,
    Journal articles | 2009
    Chan DC; Watts GF; Ooi EMM; Rye KA; Ji J; Johnson AG; Barrett PHR, 2009, 'Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome', Diabetes Care, 32, pp. 2111 - 2113,
    Journal articles | 2009
    Fryirs M; Barter P; Tabet F; Heather A; Rye K, 2009, 'Abstract: 1043 HIGH DENSITY LIPOPROTEINS (HDL) INCREASE PANCREATIC B-CELL INSULIN SECRETION', Atherosclerosis Supplements, 10, pp. e403 - e403,
    Journal articles | 2009
    Fryirs M; Barter PJ; Rye KA, 2009, 'Cholesterol metabolism and pancreatic β-cell function', Current Opinion in Lipidology, 20, pp. 159 - 164,
    Journal articles | 2009
    Heather A; Li X-H; McGrath K; Rye K; Barter P, 2009, 'Abstract: 1066 HIGH DENSITY LIPOPROTEINS (HDLS) INDUCE A MILD OXIDATIVE STRESS RESPONSE IN HUMAN ENDOTHELIAL CELLS THAT INCREASES CELLULAR ANTIOXIDANT PROTEIN EXPRESSION AND PROTECTS AGAINST INFLAMMATORY INSULT', Atherosclerosis Supplements, 10, pp. e415 - e415,
    Journal articles | 2009
    Heather AK; Li XH; McGrath KCY; Rye KA; Barter PJ, 2009, 'HDL induces anergy to proinflammatory cytokines in endothelial cells through a mild oxidative stress response', Heart, Lung and Circulation, 18, pp. S243 - S243,
    Journal articles | 2009
    Kiya Y; Miura SI; Imaizumi S; Uehara Y; Matsuo Y; Abe S; Jimi S; Urata H; Rye KA; Saku K, 2009, 'Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats', Atherosclerosis, 203, pp. 137 - 144,
    Journal articles | 2009
    Lambert G; Charlton F; Rye KA; Piper DE, 2009, 'Molecular basis of PCSK9 function', Atherosclerosis, 203, pp. 1 - 7,
    Journal articles | 2009
    Li L; Bursill C; Barter P; Rye K, 2009, 'Abstract: 1112 EVIDENCE THAT APOA-II IS ANTI-INFLAMMATORY IN VITRO AND IN VIVO', Atherosclerosis Supplements, 10, pp. e442 - e442,
    Journal articles | 2009
    Liong E; McGrath K; Tan J; Li X-H; Dy V; Barter P; Rye K; Heather A, 2009, 'Abstract: 1510 ROLE OF 3B-HYDROXYSTEROID-[DELTA]24 REDUCTASE IN MEDIATING THE ANTI-INFLAMMATORY EFFECTS OF HIGH-DENSITY LIPOPROTEINS IN ENDOTHELIAL CELLS', Atherosclerosis Supplements, 10, pp. e464 - e464,
    Journal articles | 2009
    McGrath KCY; Li XH; Puranik R; Liong EC; Tan JTM; Dy VM; Dibartolo BA; Barter PJ; Rye KA; Heather AK, 2009, 'Role of 3β-hydroxysteroid-Δ24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells', Arteriosclerosis, Thrombosis, and Vascular Biology, 29, pp. 877 - 882,
    Journal articles | 2009
    Patel S; Drew BG; Nakhla S; Duffy SJ; Murphy AJ; Barter PJ; Rye KA; Chin-Dusting J; Hoang A; Sviridov D; Celermajer DS; Kingwell BA, 2009, 'Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes', Journal of the American College of Cardiology, 53, pp. 962 - 971,
    Journal articles | 2009
    Patel S; Puranik R; Nakhla S; Lundman P; Stocker R; Wang X; Lambert G; Rye KA; Barter P; Nicholls S; Celermajer D, 2009, 'Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-intlammatory capacity of high density lipoproteins', Atherosclerosis, 204, pp. 424 - 428,
    Journal articles | 2009
    Peshavariya H; Dusting GJ; Di Bartolo B; Rye KA; Barter PJ; Jiang F, 2009, 'Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts', Free Radical Research, 43, pp. 772 - 782,
    Journal articles | 2009
    Reimers G; Rickards J; Chan P; Rye K-A; Cohn J; Jackson C; Barter P; Rodgers K, 2009, 'Abstract: P290 PREVENTION OF RUPTURE OF ESTABLISHED ATHEROSCLEROTIC PLAQUES BY TREATMENT WITH APOLIPOPROTEIN A-I DUE TO MODULATION OF SMOOTH MUSCLE CELL PHENOTYPE', Atherosclerosis Supplements, 10, pp. e598 - e598,
    Journal articles | 2009
    Rye KA; Bursill CA; Lambert G; Tabet F; Barter PJ, 2009, 'The metabolism and anti-atherogenic properties of HDL', Journal of Lipid Research, 50,
    Journal articles | 2009
    Tabet F; Lambert G; Jenkins A; Barter P; Rye K-A, 2009, 'Abstract: P1202 THE ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF APOLIPOPROTEIN (APO) A-I FROM DIABETIC PATIENTS ARE IMPAIRED', Atherosclerosis Supplements, 10, pp. e309 - e309,
    Journal articles | 2009
    Tabet F; Lambert G; Jenkins AJ; Barter PJ; Rye KA, 2009, 'The anti-oxidant and anti-inflammatory properties of lipid-free and lipid-associated apolipoprotein A-I, in diabetes', Heart, Lung and Circulation, 18, pp. S249 - S249,
    Journal articles | 2009
    Tabet F; Remaley A; Barter P; Rye K-A; Lambert G, 2009, 'Abstract: 1458 THE 5A APOA-I MIMETIC PEPTIDE DISPLAYS ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES MEDIATED BY ABCA1', Atherosclerosis Supplements, 10, pp. e98 - e98,
    Journal articles | 2009
    Tabet F; Remaley AT; Barter PJ; Rye KA; Lambert G, 2009, 'The Cardioprotective Properties of the Novel 5A Apolipoprotein A-I Mimetic Peptide are Mediated via the ABCA1 Transporter', Heart, Lung and Circulation, 18, pp. S124 - S124,
    Journal articles | 2009
    Tabet F; Rye KA, 2009, 'High-density lipoproteins, inflammation and oxidative stress', Clinical Science, 116, pp. 87 - 98,
    Journal articles | 2009
    Tan JTM; Rye KA; Barter PJ; Heather AK, 2009, 'Role of DHCR24 in Mediating the Anti-inflammatory Effects of HDL in Human Coronary Artery Endothelial Cells', Heart, Lung and Circulation, 18, pp. S2 - S2,
    Journal articles | 2009
    Wu B; Yan L; Charlton F; Rye K-A, 2009, 'Abstract: 1008 NIACIN INHIBITS ACUTE VASCULAR INFLAMMATION IN RABBITS', Atherosclerosis Supplements, 10, pp. e383 - e383,
    Journal articles | 2009
    Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A, 2009, 'HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: Relevance to inflammation and atherogenesis', Arteriosclerosis, Thrombosis, and Vascular Biology, 29, pp. 2169 - 2175,
    Journal articles | 2009
    Zerrad-Saadi A; Therond P; Couturier M; Chantepie S; Rye K; Chapman M; Kontush A, 2009, 'Abstract: 82 MECHANISMS IMPLICATED IN THE POTENT PROTECTION OF LDL FROM OXIDATIVE STRESS MEDIATED BY SMALL, DENSE HDL3', Atherosclerosis Supplements, 10, pp. e221 - e221,
    Journal articles | 2009
    di Bartolo B; Bursill C; Rye K-A; Nicholls S; Heather A; Barter P, 2009, 'Abstract: 1111 ANTI-INFLAMMATORY PROPERTIES OF RECONSITUTED HDL IN A CHRONIC MODEL OF INFLAMMATION', Atherosclerosis Supplements, 10, pp. e441 - e441,
    Journal articles | 2009
    di Bartolo B; Bursill C; Rye K-A; Nicholls S; Heather A; Barter P, 2009, 'Abstract: P1154 IN VITRO PROPERTIES OF AN APOLIPOPROTEIN A-I MIMETIC PEPTIDE', Atherosclerosis Supplements, 10, pp. e1180 - e1180,
    Journal articles | 2008
    Barter PJ; Rye KA, 2008, 'Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?', Arteriosclerosis, Thrombosis, and Vascular Biology, 28, pp. 39 - 46,
    Journal articles | 2008
    Chan LL; Kim WS; Kwok JB; Hill AF; Cappai R; Rye K; Garner B, 2008, 'ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro', Journal of Neurochemistry, 106, pp. 793 - 804
    Journal articles | 2008
    Glaros EN; Kim WS; Quinn CM; Jessup W; Rye K; Garner B, 2008, 'Myriocin slows the progression of established atherosclerotic lesions in apolipoprotein E gene knockout mice', Journal of Lipid Research, 49, pp. 324 - 331,
    Journal articles | 2008
    Glaros EN; Kim WS; Rye K; Shayman J; Garner B, 2008, 'Reduction of plasma glycosphingolipid levels has no impact on atherosclerosis in apolipoprotein E-null mice', Journal of Lipid Research, 49, pp. 1677 - 1681,
    Journal articles | 2008
    91˰涶r VM; Marais AD; Charlton F; Laurie AD; Hurndell N; Scott R; Mangili F; Sullivan DR; Barter PJ; Rye KA; George PM; Lambert G, 2008, 'Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa', Atherosclerosis, 196, pp. 659 - 666,
    Journal articles | 2008
    Imaizumi S; Miura SI; Nakamura K; Kiya Y; Uehara Y; Zhang B; Matsuo Y; Urata H; Ideishi M; Rye KA; Sata M; Saku K, 2008, 'Antiarrhythmogenic Effect of Reconstituted High-Density Lipoprotein Against Ischemia/Reperfusion in Rats', Journal of the American College of Cardiology, 51, pp. 1604 - 1612,
    Journal articles | 2008
    Kim WS; Elliott DA; Kockx M; Kritharides L; Rye K; Jans D; Garner B, 2008, 'Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches', Biochemical Journal, 409, pp. 701 - 709,
    Journal articles | 2008
    Lambert G; Ancellin N; Charlton F; Comas D; Pilot J; Keech A; Patel S; Sullivan DR; Cohn JS; Rye KA; Barter PJ, 2008, 'Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment', Clinical Chemistry, 54, pp. 1038 - 1045,
    Journal articles | 2008
    Miura S; Imaizumi S; Kiya Y; Sata M; Rye KA; Saku K, 2008, 'RECONSTITUTED HDL THERAPY FOR CARDIOVASCULAR DISEASE', Atherosclerosis Supplements, 9, pp. 17 - 17,
    Journal articles | 2008
    Nobécourt E; Zeng J; Davies MJ; Brown BE; Yadav S; Barter PJ; Rye KA, 2008, 'Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I', Diabetologia, 51, pp. 1008 - 1017,
    Journal articles | 2008
    Patel S; Drew B; Nakhla S; Barter P; Rye K-A; Kingwell B; Celermajer D, 2008, 'The Anti-inflammatory Capacity of Human High Density Lipoproteins (HDL) is Significantly Enhanced after Infusion of Reconstituted HDL “In Vivo”', Heart, Lung and Circulation, 17, pp. S2 - S3,
    Journal articles | 2008
    Patel S; Sieveking D; Barter P; Rye K-A; Celermajer D; Ng M, 2008, 'Reconstituted High-density Lipoproteins (rHDL), Lipid-free Apolipoprotein A-I (lipid-free apoA-I) and Plasma HDL Inhibit Tubulogenesis in an Endothelial Cell-specific Model of Angiogenesis', Heart, Lung and Circulation, 17, pp. S16 - S16,
    Journal articles | 2008
    Puranik R; Bao S; Nobecourt E; Nicholls SJ; Dusting GJ; Barter PJ; Celermajer DS; Rye KA, 2008, 'Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo', Atherosclerosis, 196, pp. 240 - 247,
    Journal articles | 2008
    Rye KA; Barter PJ, 2008, 'Antiinflammatory actions of HDL. A new insight', Arteriosclerosis, Thrombosis, and Vascular Biology, 28, pp. 1890 - 1891,
    Journal articles | 2008
    Settasatian N; Barter PJ; Rye KA, 2008, 'Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein', Journal of Lipid Research, 49, pp. 115 - 126,
    Journal articles | 2008
    Silva RAGD; Huang R; Morris J; Fang J; Gracheva EO; Ren G; Kontush A; Jerome WG; Rye KA; Davidson WS, 2008, 'Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes', Proceedings of the National Academy of Sciences of the United States of America, 105, pp. 12176 - 12181,
    Journal articles | 2008
    Uehara Y; Tsuboi Y; Zhang B; Miura SI; Baba Y; Higuchi MA; Yamada T; Rye KA; Saku K, 2008, 'POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease', Atherosclerosis, 197, pp. 283 - 289,
    Journal articles | 2007
    Barter PJ; Puranik R; Rye KA, 2007, 'New insights into the role of HDL as an anti-inflammatory agent in the prevention of cardiovascular disease', Current Cardiology Reports, 9, pp. 493 - 498,
    Journal articles | 2007
    Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye K; Stocker R; Jessup W; Garner B, 2007, 'Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration', Biochemical Pharmacology, 73, pp. 1340 - 1346
    Journal articles | 2007
    Kim WS; Rahmanto A; Kamili A; Rye K; Guillemin GJ; Gelissen I; Jessup W; Hill A; Garner B, 2007, 'Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generation', The Journal of Biological Chemistry, 282, pp. 2851 - 2861
    Journal articles | 2007
    Matsuo Y; Miura SI; Kawamura A; Uehara Y; Rye KA; Saku K, 2007, 'Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation', Atherosclerosis, 194, pp. 159 - 168,
    Journal articles | 2007
    Ng TWK; Watts GF; Barrett PHR; Rye KA; Chan DC, 2007, 'Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels', Diabetes Care, 30, pp. 2945 - 2950,
    Journal articles | 2007
    Ng TWK; Watts GF; Barrett PHR; Rye KA; Chan DCF, 2007, 'LB-PO-867 EFFECT OF WEIGHT LOSS ON LDL AND HDL METABOLISM: INDEPENDENT REGULATORY ROLES OF ADIPONECTIN BUT NOT RETINOL-BINDING PROTEIN-4', Atherosclerosis Supplements, 8, pp. 232 - 232,
    Journal articles | 2007
    Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA, 2007, 'The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase', Diabetologia, 50, pp. 643 - 653,
    Journal articles | 2007
    Ooi EMM; Chan DC; Rye KA; Watts GF, 2007, 'Differences in plasma PLTP activity assays: Constant or random error? [2]', Clinical Endocrinology, 67, pp. 317,
    Journal articles | 2007
    Patel S; Barter PJ; Celermajer DS; Rye K-A, 2007, 'The Fate of Reconstituted High Density Lipoproteins in Vivo', Heart, Lung and Circulation, 16, pp. S167 - S167,
    Journal articles | 2007
    Patel S; Drew B; Duffy S; Nahkla S; Rye K-A; Barter P; Celermajer D; Kingwell B, 2007, 'Abstract 1047: Infusion of Reconstituted High Density Lipoproteins Into Humans Enhances the In Vitro Anti-Inflammatory Capacity of the High Density Lipoprotein Fraction.', Circulation, 116,
    Journal articles | 2007
    Patel S; Puranik R; Nakhla S; Lundman P; Rye K; Barter PJ; Nicholls SJ; Celermajer DS, 2007, 'Transient Triglyceridaemia Reduces the Anti-inflammatory Properties of High-density Lipoprotein', Heart, Lung and Circulation, 16, pp. S167 - S168,
    Journal articles | 2007
    Skropeta D; Settasatian C; McMahon MR; Shearston K; Caiazza D; McGrath KC; Jin W; Rader DJ; Barter PJ; Rye KA, 2007, 'N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins', Journal of Lipid Research, 48, pp. 2047 - 2057,
    Journal articles | 2007
    Sumi M; Sata M; Miura SI; Rye KA; Toya N; Kanaoka Y; Yanaga K; Ohki T; Saku K; Nagai R, 2007, 'Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis', Arteriosclerosis, Thrombosis, and Vascular Biology, 27, pp. 813 - 818,
    Journal articles | 2007
    Watts GF; Ji J; Chan DC; Ooi EMM; Johnson AG; Rye KA; Barrett PHR, 2007, 'Erratum: Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome (Clinical Science (2006) 111, (193-199))', Clinical Science, 112, pp. 625,
    Journal articles | 2007
    Zhang B; Uehara Y; Hida S; Miura SI; Rainwater DL; Segawa M; Kumagai K; Rye KA; Saku K, 2007, 'Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis', Journal of Lipid Research, 48, pp. 1175 - 1189,
    Journal articles | 2006
    Barrett PHR; Kee P; Caiazza D; Rye KA; Morehouse LA; Barter PJ, 2006, 'We-W38:5 Effect of inhibiting cholesteryl ester transfer protein on the kinetics of HDL cholesteryl ester transport in plasma: In vivo studies in rabbits', Atherosclerosis Supplements, 7, pp. 322 - 322,
    Journal articles | 2006
    Barter P; Rye KA, 2006, 'Are we lowering LDL cholesterol sufficiently?', Nature Clinical Practice Cardiovascular Medicine, 3, pp. 290 - 291,
    Journal articles | 2006
    Barter PJ; Rye KA; Gotto AM, 2006, 'The argument against the appropriateness of over-the-counter statins', Circulation, 114, pp. 1315 - 1320,
    Journal articles | 2006
    Barter PJ; Rye KA, 2006, 'Cardioprotective properties of fibrates: Which fibrate, which patients, what mechanism?', Circulation, 113, pp. 1553 - 1555,
    Journal articles | 2006
    Barter PJ; Rye KA, 2006, 'Homocysteine and cardiovascular disease: Is HDL the link?', Circulation Research, 99, pp. 565 - 566,
    Journal articles | 2006
    Barter PJ; Rye KA, 2006, 'Relationship between the concentration and antiatherogenic activity of high-density lipoproteins', Current Opinion in Lipidology, 17, pp. 399 - 403,
    Journal articles | 2006
    Brown BE; Nobecourt E; Rye K-A; Davies MJ, 2006, 'Glycation of lipid-free apolipoprotein A-I impairs cholesterol efflux from macrophages', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 541 - 541,
    Journal articles | 2006
    Curtiss LK; Valenta DT; Hime NJ; Rye KA, 2006, 'What is so special about apolipoprotein AI in reverse cholesterol transport?', Arteriosclerosis, Thrombosis, and Vascular Biology, 26, pp. 12 - 19,
    Journal articles | 2006
    Gelissen I; Rye K-A; Quinn C; Brown A; Kockx M; Cartland S; Kritharides L; Jessup W, 2006, 'Concerted action of ABCA1 and ABCG1 in cell cholesterol export', Vascular Pharmacology, 45, pp. e23 - e23,
    Journal articles | 2006
    Gotto AM; Barter PJ; Rye KA, 2006, 'Over-the-counter statins are worth considering in primary prevention of cardiovascular disease', Circulation, 114, pp. 1310 - 1314,
    Journal articles | 2006
    Heather AK; McGrath KC-Y; Puranik R; Tsatralis T; Celermajer D; Barter P; Rye K, 2006, 'Tu-P7:218 HDL exerts novel anti-inflammatory effects on endothelial cells via the suppression on NFKB', Atherosclerosis Supplements, 7, pp. 232 - 232,
    Journal articles | 2006
    Hime NJ; Drew KJ; Wee K; Barter PJ; Rye KA, 2006, 'Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit', Journal of Lipid Research, 47, pp. 115 - 122,
    Journal articles | 2006
    Imaizumi S; Miura S; Kiya Y; Zhang B; Uehara Y; Rye KA; Saku K, 2006, 'Pharmacological intervention using reconstituted high-density lipoprotein changes the lipid profile in spontaneously hypersensitive rats', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 562 - 562,
    Journal articles | 2006
    Jessup W; Gelissen I; Kritharides L; Quinn CM; Kockx M; Brown AJ; Rye K; Harris M; Packianathan M; Cartland SP, 2006, 'ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I', Arteriosclerosis, Thrombosis and Vascular Biology, 26, pp. 534 - 540
    Journal articles | 2006
    Ji J; Barrett PHR; Johnson AG; Chan DC; Serone AP; Rye KA; Watts GF, 2006, 'Lipid transfer proteins and apolipoprotein B-100 metabolism in the metabolic syndrome treated with fenofibrate', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 370 - 370,
    Journal articles | 2006
    Ji J; Watts GF; Johnson AG; Chan DC; Ooi EMM; Rye KA; Serone AP; Barrett PHR, 2006, 'High-density lipoprotein (HDL) transport in the metabolic syndrome: Application of a new model for HDL particle kinetics', Journal of Clinical Endocrinology and Metabolism, 91, pp. 973 - 979,
    Journal articles | 2006
    Ji J; Watts GF; Johnson AG; Chan DC; Ooi EMM; Rye KA; Serone AP; Barrett PHR, 2006, 'High-density lipoprotien transport in the metabolic syndrome: Application of a new model for HDL particle kinetics', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 534 - 534,
    Journal articles | 2006
    Kee P; Caiazza D; Rye KA; Barrett PHR; Morehouse LA; Barter PJ, 2006, 'Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: In vivo studies in rabbits', Arteriosclerosis, Thrombosis, and Vascular Biology, 26, pp. 884 - 890,
    Journal articles | 2006
    Matsuo Y; Miura S; Kiya Y; Uehara Y; Imaizumi S; Rye KA; Saku K, 2006, 'Th-P15:197 Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation', Atherosclerosis Supplements, 7, pp. 536 - 536,
    Journal articles | 2006
    Miura S; Kiya Y; Imaizumi S; Zhang B; Matsuo Y; Uehara Y; Rye KA; Saku K, 2006, 'Peiotropic action of HDL and HDL therapy', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 561 - 561,
    Journal articles | 2006
    Nicholls SJ; Lundman P; Harmer JA; Cutri B; Griffiths KA; Rye KA; Barter PJ; Celermajer DS, 2006, 'Consumption of Saturated Fat Impairs the Anti-Inflammatory Properties of High-Density Lipoproteins and Endothelial Function', Journal of the American College of Cardiology, 48, pp. 715 - 720,
    Journal articles | 2006
    Nobecourt E; Davies M; Zeng J; Rye K-A, 2006, 'Mo-P1:113 Inhibition of apolipoprotein A-I glycation restores its ability to activate lecithin: Cholesterol acyl transferase', Atherosclerosis Supplements, 7, pp. 71 - 71,
    Journal articles | 2006
    Nobecourt E; Puranik RAJ; Bao S; Davies M; Barter P; Rye K-A, 2006, 'Mo-P1:114 Evidence that glycation of apolipoprotein A-I inhibits the anti-inflammatory properties of HDL in vivo', Atherosclerosis Supplements, 7, pp. 71 - 71,
    Journal articles | 2006
    Ooi EMM; Watts GF; Ji J; Johnson AG; Rye KA; Chan DC; Barrett PHR, 2006, 'Balancing feedback and lipoprotein transport in the metabolic syndrome', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 577 - 577,
    Journal articles | 2006
    Ooi EMM; Watts GF; Ji J; Rye KA; Johnson AG; Chan DC; Barrett PHR, 2006, 'Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo', Clinical Endocrinology, 65, pp. 752 - 759,
    Journal articles | 2006
    Ooi EMM; Watts GF; Ji J; Rye KA; Johnson AG; Chan DC; Barrett PHR, 2006, 'Role of plasma phospholipid transfer protein activity in determining HDL kinetics in vivo', ATHEROSCLEROSIS SUPPLEMENTS, 7, pp. 535 - 535,
    Journal articles | 2006
    Rentero C; Tebar F; de Muga S; Cubells L; de Diego M; Hayes T; Hughes WE; Pol A; Rye K; Enrich C; Grewal T; Wood P; Evans R, 2006, 'Inhibition of H-Ras and MAPK is compensated by PKC-dependent pathways in annexin A6 expressing cells', Cellular Signalling, 18, pp. 1006 - 1016
    Journal articles | 2006
    Rye K-A; Puranik R; Nobecourt E; Bao S; Nicholls SJ; Barter PJ, 2006, 'Tu-W16:1 HDL and the inhibition of inflammation in vivo', Atherosclerosis Supplements, 7, pp. 152 - 152,
    Journal articles | 2006
    Rye KA; Bright R; Psaltis M; Barter PJ, 2006, 'Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E', Journal of Lipid Research, 47, pp. 1025 - 1036,
    Journal articles | 2006
    Tso C; Martinic G; Fan WH; Rogers C; Rye KA; Barter PJ, 2006, 'High-density lipoproteins enhance progenitor-mediated endothelium repair in mice', Arteriosclerosis, Thrombosis, and Vascular Biology, 26, pp. 1144 - 1149,
    Journal articles | 2006
    Watts GF; Ji J; Chan DC; Ooi EMM; Johnson AG; Rye KA; Barrett PHR, 2006, 'Relationships between changes in plasma lipid transfer proteins and apolipoprotein B-100 kinetics during fenofibrate treatment in the metabolic syndrome', Clinical Science, 111, pp. 193 - 199,
    Journal articles | 2006
    Zhang B; Katafuchi R; Arishima H; Matsunaga A; Rye KA; Saku K, 2006, 'Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis', Clinica Chimica Acta, 373, pp. 55 - 61,
    Journal articles | 2006
    Zhang B; Miura SI; Fan P; Kumagai K; Takeuchi K; Uehara Y; McMahon M; Rye KA; Saku K, 2006, 'ApoA-I/phosphatidylcholine discs remodels fast-migrating HDL into slow-migrating HDL as characterized by capillary isotachophoresis', Atherosclerosis, 188, pp. 95 - 101,
    Journal articles | 2005
    Gelissen I; Packianathan M; Rye K; Harris ML; Quinn CM; Kritharides L; Jessup W, 2005, 'ABCG1 mediated cholesterol efflux from cells', Atherosclerosis Supplements, 6, pp. 55 - 55
    Journal articles | 2005
    Grewal T; Evans R; Rentero C; Tebar F; Cubells L; de Diego I; Kirchhoff M; Hughes WE; Heeren J; Rye K; Rinninger F; Daly RJ; Pol A; Enrich C, 2005, 'Annexin A6 stimulates the membrane recruitment of p120GAP to modulate Ras and Raf-1 activity', Oncogene, 24, pp. 5809 - 5820
    Journal articles | 2005
    Jahangiri A; Rader DJ; Marchadier D; Curtiss LK; Bonnet DJ; Rye KA, 2005, 'Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I', Journal of Lipid Research, 46, pp. 896 - 903,
    Journal articles | 2005
    Jänis MT; Metso J; Lankinen H; Strandin T; Olkkonen VM; Rye KA; Jauhiainen M; Ehnholm C, 2005, 'Apolipoprotein E activates the low-activity form of human phospholipid transfer protein', Biochemical and Biophysical Research Communications, 331, pp. 333 - 340,
    Journal articles | 2005
    Nicholls SJ; Cutri B; Worthley SG; Kee P; Rye KA; Bao S; Barter PJ, 2005, 'Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits', Arteriosclerosis, Thrombosis, and Vascular Biology, 25, pp. 2416 - 2421,
    Journal articles | 2005
    Nicholls SJ; Dusting GJ; Cutri B; Bao S; Drummond GR; Rye KA; Barter PJ, 2005, 'Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits', Circulation, 111, pp. 1543 - 1550,
    Journal articles | 2005
    Nicholls SJ; Rye KA; Barter PJ, 2005, 'High-density lipoproteins as therapeutic targets', Current Opinion in Lipidology, 16, pp. 345 - 349,
    Journal articles | 2005
    Raftery MJ; Campbell R; Glaros EN; Rye K; Halliday GM; Jessup W; Garner B, 2005, 'Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro.', Biochemistry, 44, pp. 7346 - 7353
    Journal articles | 2004
    Barter PJ; Nicholls S; Rye KA; Anantharamaiah GM; Navab M; Fogelman AM, 2004, 'Antiinflammatory properties of HDL', Circulation Research, 95, pp. 764 - 772,
    Journal articles | 2004
    Caiazza D; Jahangiri A; Rader DJ; Marchadier D; Rye KA, 2004, 'Apolipoproteins regulate the kinetics of endothelial lipase-mediated hydrolysis of phospholipids in reconstituted high-density lipoproteins', Biochemistry, 43, pp. 11898 - 11905,
    Journal articles | 2004
    Heeren J; Grewal T; Laatsch A; Becker NG; Rinninger F; Rye K; Beisiegel U, 2004, 'Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation', The Journal of Biological Chemistry, 279, pp. 55483 - 55492
    Journal articles | 2004
    Hime NJ; Drew KJ; Hahn C; Barter PJ; Rye KA, 2004, 'Apolipoprotein E enhances hepatic lipase-mediated hydrolysis of reconstituted high-density lipoprotein phospholipid and triacylglycerol in an isoform-dependent manner', Biochemistry, 43, pp. 12306 - 12314,
    Journal articles | 2004
    Kockx M; Rye K; Gaus K; Quinn CM; Wright J; Sloane T; Sviridov D; Fu YL; Sullivan D; Burnett J; Rust S; Assmann G; Anantharamaiah G; Palgunachari M; Katz S; Phillips MA; Dean R; Jessup W; Kritharides L, 2004, 'Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux', The Journal of Biological Chemistry, 279, pp. 25966 - 25977
    Journal articles | 2004
    Rye KA; Barter PJ, 2004, 'Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I', Arteriosclerosis, Thrombosis, and Vascular Biology, 24, pp. 421 - 428,
    Journal articles | 2004
    Wadham C; Albanese N; Roberts J; Wang L; Bagley C; Gamble J; Rye K-A; Barter P; Vadas M; Xia P, 2004, 'HIGH-DENSITY LIPOPROTEINS NEUTRALISE C-REACTIVE PROTEIN PROINFLAMMATORY ACTIVITY', Cardiovascular Pathology, 13, pp. 31 - 31,
    Journal articles | 2004
    Wadham C; Albanese N; Roberts J; Wang L; Bagley CJ; Gamble JR; Rye KA; Barter PJ; Vadas MA; Xia P, 2004, 'High-Density Lipoproteins Neutralize C-Reactive Protein Proinflammatory Activity', Circulation, 109, pp. 2116 - 2122,
    Journal articles | 2003
    Duong MN; Psaltis M; Rader DJ; Marchadier D; Barter PJ; Rye KA, 2003, 'Evidence That Hepatic Lipase and Endothelial Lipase Have Different Substrate Specificities for High-Density Lipoprotein Phospholipids', Biochemistry, 42, pp. 13778 - 13785,
    Journal articles | 2003
    Hime N; Drew K; Hahn C; Rye K-A, 2003, '3P-0730 Influence of apolipoprotein E isoforms on hepatic lipase-mediated phospholipid and triacylglycerol hydrolysis in reconstituted high density lipoproteins', Atherosclerosis Supplements, 4, pp. 222 - 222,
    Journal articles | 2003
    Hime N; Wee K; Barter P; Rye K-A, 2003, '3P-0731 In vivo formation of high density lipoproteins containing both apolipoprotein A-I and apolipoprotein A-II in the rabbit', Atherosclerosis Supplements, 4, pp. 222 - 222,
    Journal articles | 2003
    Jahangiri A; Rader D; Marchadier D; Rye K-A, 2003, '4P-1026 Apolipoproteins regulate the remodelling of high density lipoproteins by endothelial lipase', Atherosclerosis Supplements, 4, pp. 300 - 300,
    Journal articles | 2003
    Rye KA; Wee K; Curtiss LK; Bonnet DJ; Barter PJ, 2003, 'Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation', Journal of Biological Chemistry, 278, pp. 22530 - 22536,
    Journal articles | 2002
    Barter PJ; Baker PW; Rye KA, 2002, 'Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells', Current Opinion in Lipidology, 13, pp. 285 - 288,
    Journal articles | 2002
    Kee P; Rye KA; Taylor JL; Barrett PHR; Barter PJ, 2002, 'Metabolism of ApoA-I as lipid-free protein or as component of discoidal and spherical reconstituted HDLs: Studies in wild-type and hepatic lipase transgenic rabbits', Arteriosclerosis, Thrombosis, and Vascular Biology, 22, pp. 1912 - 1917,
    Journal articles | 2002
    Rye K; Duong M; Psaltis MK; Curtiss LK; Bonnet DJ; Stocker R; Barter P, 2002, 'Evidence that Phospholipids Play a Key Role in Pre-B ApoA-I Formation and High-Density Lipoprotein Remodeling', Biochemistry, 41, pp. 12538 - 12545
    Journal articles | 2001
    Ashby D; Gamble J; Vadas M; Fidge N; Siggins S; Rye KA; Barter PJ, 2001, 'Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression', Atherosclerosis, 154, pp. 113 - 121,
    Journal articles | 2001
    Barter PJ; Rye KA, 2001, 'Cholesteryl ester transfer protein, high density lipoprotein and arterial disease', Current Opinion in Lipidology, 12, pp. 377 - 382,
    Journal articles | 2001
    Clay MA; Pyle DH; Rye KA; Vadas MA; Gamble JR; Barter PJ, 2001, 'Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins', Atherosclerosis, 157, pp. 23 - 29,
    Journal articles | 2001
    Hime NJ; Barter PJ; Rye KA, 2001, 'Evidence that apolipoprotein A-I facilitates hepatic lipase-mediated phospholipid hydrolysis in reconstituted HDL containing apolipoprotein A-II', Biochemistry, 40, pp. 5496 - 5505,
    Journal articles | 2001
    Settasatian N; Duong MN; Curtiss LK; Ehnholm C; Jauhiainen M; Huuskonen J; Rye KA, 2001, 'The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer Protein', Journal of Biological Chemistry, 276, pp. 26898 - 26905,
    Journal articles | 2000
    Baker PW; Rye K-A; Gamble JR; Vadas MA; Barter PJ, 2000, 'Inhibition of endothelial cell adhesion molecule expression by reconstituted high-density lipoproteins: Determinants and characteristics', Atherosclerosis, 151, pp. 190 - 190,
    Journal articles | 2000
    Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ, 2000, 'Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression', Journal of Lipid Research, 41, pp. 1261 - 1267
    Journal articles | 2000
    Clay MA; Pyle DH; Rye KA; Barter PJ, 2000, 'Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase', Journal of Biological Chemistry, 275, pp. 9019 - 9025,
    Journal articles | 2000
    Curtiss LK; Bonnet DJ; Rye KA, 2000, 'The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: A surface plasmon resonance study', Biochemistry, 39, pp. 5712 - 5721,
    Journal articles | 2000
    Duong M; Rye KA, 2000, 'The influence of phospholipid acyl chain composition on the hepatic lipase-mediated hydrolysis of HDL phospholipids', Atherosclerosis, 151, pp. 181 - 181,
    Journal articles | 2000
    Hime NJ; Barter PJ; Rye K-A, 2000, 'The influence of apolipoproteins on hepatic lipase-mediated phospholipid hydrolysis in reconstituted high density lipoproteins', Atherosclerosis, 151, pp. 181 - 181,
    Journal articles | 2000
    Panzenbock U; Kritharides L; Raftery MJ; Rye K; Stocker R, 2000, 'Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I', The Journal of Biological Chemistry, pp. 19536 - 19544
    Journal articles | 2000
    Panzenböck U; Raftery M; Kritharides L; Rye K-A; Perry R; Francis G; Stocker R, 2000, 'Oxidation of specific Met residues does not decrease anti-atherogenic activities of apolipoprotein A-I', Atherosclerosis, 151, pp. 165 - 165,
    Journal articles | 2000
    Rye KA; My Ngan Duong , 2000, 'Influence of phospholipid depletion on the size, structure, and remodeling of reconstituted high density lipoproteins', Journal of Lipid Research, 41, pp. 1640 - 1650
    Journal articles | 2000
    Settasatian N; Curtiss LK; Ehnholm C; Jauhiainen M; Rye K-A, 2000, 'Influence of triglyceride enrichment on the remodelling of high density lipoproteins by PLTP', Atherosclerosis, 151, pp. 181 - 181,
    Journal articles | 1999
    Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ, 1999, 'Ability of reconstituted high density lipoproteins to inhibit cytokine- induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells', Journal of Lipid Research, 40, pp. 345 - 353
    Journal articles | 1999
    Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ, 1999, 'Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II', Biochemical Journal, 337, pp. 445 - 451,
    Journal articles | 1999
    Gelissen IC; Rye KA; Brown AJ; Dean RT; Jessup W, 1999, 'Oxysterol efflux from macrophage foam cells: The essential role of acceptor phospholipid', Journal of Lipid Research, 40, pp. 1636 - 1646
    Journal articles | 1999
    Panzenboeck U; Rye KA; Kritharides L; Stocker R, 1999, 'Selective oxidation of methionine residues enhances rather than decreases potential anti-atherogenic properties of apolipoprotein AI', ATHEROSCLEROSIS, 144, pp. 6 - 6,
    Journal articles | 1999
    Rye KA; Clay MA; Barter PJ, 1999, 'Remodelling of high density lipoproteins by plasma factors', Atherosclerosis, 145, pp. 227 - 238,
    Journal articles | 1999
    Xia P; Vadas MA; Rye KA; Barter PJ; Gamble JR, 1999, 'High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against a therosclerosis by HDL', Journal of Biological Chemistry, 274, pp. 33143 - 33147,
    Journal articles | 1998
    Ashby DT; Rye KA; Clay MA; Vadas MA; Gamble JR; Barter PJ, 1998, 'Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells', Arteriosclerosis, Thrombosis, and Vascular Biology, 18, pp. 1450 - 1455,
    Journal articles | 1998
    Garner B; Waldeck AR; Witting PK; Rye KA; Stocker R, 1998, 'Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII', Journal of Biological Chemistry, 273, pp. 6088 - 6095,
    Journal articles | 1998
    Hime NJ; Barter PJ; Rye KA, 1998, 'The influence of apolipoproteins on the hepatic lipase-mediated hydrolysis of high density lipoprotein phospholipid and triacylglycerol', Journal of Biological Chemistry, 273, pp. 27191 - 27198,
    Journal articles | 1998
    James MJ; Van Reyk D; Rye KA; Dean RT; Cleland LG; Barter PJ; Jessup W, 1998, 'Low density lipoprotein of synovial fluid in inflammatory joint disease is mildly oxidized', Lipids, 33, pp. 1115 - 1121,
    Journal articles | 1998
    Rye KA; Jauhiainen M; Barter PJ; Ehnholm C, 1998, 'Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein', Journal of Lipid Research, 39, pp. 613 - 622
    Journal articles | 1998
    Xia P; Gamble JR; Rye KA; Wang L; Hii CST; Cockerill P; Khew-Goodall Y; Bert AG; Barter PJ; Vadas MA, 1998, 'Tumor necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway', Proceedings of the National Academy of Sciences of the United States of America, 95, pp. 14196 - 14201,
    Journal articles | 1997
    Ashby DT; Gamble JR; Vadas MA; Rye K-A; Barter PJ, 1997, '4.P.374 Inhibition of endothelial cell adhesion molecule expression by high density lipoprotein subfractions', Atherosclerosis, 134, pp. 375 - 375,
    Journal articles | 1997
    Barter PJ; Rye K-A; Clay MA; Ashby D; Baker P; Xia P; Gamble JR; Vadas MA, 1997, '4.C.4 Anti-atherogenic effects of high density lipoproteins: Mechanisms', Atherosclerosis, 134, pp. 285 - 285,
    Journal articles | 1997
    Clay MA; Cehic D; Rye K-A; Barter PJ, 1997, '4.P.377 Formation of high density lipoprotein particles containing both apolipoproteins A-I and A-II during incubation in vitro', Atherosclerosis, 134, pp. 376 - 376,
    Journal articles | 1997
    Gelissen IC; Rye KA; Brown AJ; Dean RT; Jessup W, 1997, 'Phospholipid association with apo A-I stimulates oxysterol efflux from macrophage foam cells', ATHEROSCLEROSIS, 134, pp. 367 - 367,
    Journal articles | 1997
    Hime NJ; Barter PJ; Rye K-A, 1997, '1.P.41 The influence of apolipoprotein composition on hepatic lipase-mediated phospholipid and triacylglycerol hydrolysis in reconstituted high density lipoproteins', Atherosclerosis, 134, pp. 25 - 25,
    Journal articles | 1997
    Rye KA; Hime NJ; Barter PJ, 1997, 'Evidence that cholesteryl ester transfer protein-mediated reductions in reconstituted high density lipoprotein size involve particle fusion', Journal of Biological Chemistry, 272, pp. 3953 - 3960,
    Journal articles | 1997
    Vadas MA; Gamble JR; Rye K; Barter P, 1997, 'Regulation of leucocyte-endothelial interactions of special relevance to atherogenesis', Clinical and Experimental Pharmacology and Physiology, 24, pp. a33 - a35,
    Journal articles | 1996
    Barter PJ; Rye KA, 1996, 'High density lipoproteins and coronary heart disease', Atherosclerosis, 121, pp. 1 - 12,
    Journal articles | 1996
    Barter PJ; Rye KA, 1996, 'Molecular mechanisms of reverse cholesterol transport', Current Opinion in Lipidology, 7, pp. 82 - 87,
    Journal articles | 1996
    Contacos C; Sullivan DR; Rye KA; Funke H; Assmann G, 1996, 'A new molecular defect in the lecithin:cholesterol acyltransferase (LCAT) gene associated with fish eye disease', Journal of Lipid Research, 37, pp. 35 - 44
    Journal articles | 1996
    Kee P; Bais R; Sobecki SK; Branford S; Rye KA; Barter PJ, 1996, 'Indirect sandwich enzyme-linked immunosorbent assay (ELISA) for plasma apolipoprotein E', Annals of Clinical Biochemistry, 33, pp. 119 - 126,
    Journal articles | 1996
    Liang HQ; Rye KA; Barter PJ, 1996, 'Remodelling of reconstituted high density lipoproteins by lecithin:cholesterol acyltransferase', Journal of Lipid Research, 37, pp. 1962 - 1979
    Journal articles | 1996
    Rye KA; Hime NJ; Barter PJ, 1996, 'The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteines', Journal of Biological Chemistry, 271, pp. 4243 - 4250,
    Journal articles | 1995
    Christison JK; Rye KA; Stocker R, 1995, 'Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein', Journal of Lipid Research, 36, pp. 2017 - 2026
    Journal articles | 1995
    Cockerill GW; Rye K-A; Gamble JR; Vadas MA; Barter PJ, 1995, 'Early events in atherogenesis may be inhibited by high density lipoproteins', Atherosclerosis, 115, pp. S25 - S25,
    Journal articles | 1995
    Cockerill GW; Rye KA; Gamble JR; Vadas MA; Barter PJ, 1995, 'High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules', Arteriosclerosis, Thrombosis, and Vascular Biology, 15, pp. 1987 - 1994,
    Journal articles | 1995
    Liang HQ; Rye KA; Barter PJ, 1995, 'Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools', Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1257, pp. 31 - 37,
    Journal articles | 1995
    Rye K-A; Hime NJ; Barter PJ, 1995, 'Influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins', Atherosclerosis, 115, pp. S100 - S100,
    Journal articles | 1995
    Rye KA; Hime NJ; Barter PJ, 1995, 'The influence of cholesteryl ester transfer protein on the composition, size, and structure of spherical, reconstituted high density lipoproteins', Journal of Biological Chemistry, 270, pp. 189 - 196,
    Journal articles | 1994
    Barter P; Rye K, 1994, 'CHOLESTERYL ESTER TRANSFER PROTEIN: ITS ROLE IN PLASMA LIPID TRANSPORT', Clinical and Experimental Pharmacology and Physiology, 21, pp. 663 - 672,
    Journal articles | 1994
    Barter P; Rye KA, 1994, 'Erratum: Cholesteryl ester transfer protein: Its role in plasma lipid transport (Clinical and Experimental Pharmacology and Physiology, Vol. 21 (663-672))', Clinical and Experimental Pharmacology and Physiology, 21, pp. 933
    Journal articles | 1994
    Barter PJ; Rye KA, 1994, 'High-density lipoproteins and coronary heart disease', European Journal of Cardiovascular Prevention & Rehabilitation, 1, pp. 217 - 221,
    Journal articles | 1994
    Liang HQ; Rye KA; Barter PJ, 1994, 'Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins', Journal of Lipid Research, 35, pp. 1187 - 1199
    Journal articles | 1994
    Rye KA; Barter PJ, 1994, 'The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins', Journal of Biological Chemistry, 269, pp. 10298 - 10303
    Journal articles | 1994
    Rye KA; Hime NJ; Barter PJ, 1994, 'Influence of cholesteryl ester transfer protein on the composition, size and structure of spherical, reconstituted high density lipoproteins', Atherosclerosis, 109, pp. 224 - 224,
    Journal articles | 1993
    Barter PJ; Rajaram OV; Liang HQ; Rye KA, 1993, 'Relationship between the size and phospholipid content of low-density lipoproteins', Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1166, pp. 135 - 137,
    Journal articles | 1993
    Rye KA; Garrety KH; Barter PJ, 1993, 'Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II', Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1167, pp. 316 - 325,
    Journal articles | 1992
    Rye KA; Garrety KH; Barter PJ, 1992, 'Changes in the size of reconstituted high density lipoproteins during incubation with cholesteryl ester transfer protein: The role of apolipoproteins', Journal of Lipid Research, 33, pp. 215 - 224
    Journal articles | 1990
    Barter PJ; Chang LBF; Newnham HH; Rye KA; Rajaram OV, 1990, 'The interaction of cholesteryl ester transfer protein and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins', Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1045, pp. 81 - 89,
    Journal articles | 1990
    Clay MA; Rye KA; Barter PJ, 1990, 'Evidence in vitro that hepatic lipase reduces the concentration of apolipoprotein A-I in rabbit high-density lipoproteins', Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1044, pp. 50 - 56,
    Journal articles | 1990
    Rye KA, 1990, 'Interaction of apolipoprotein A-II with recombinant HDL containing egg phosphatidylcholine, unesterified cholesterol and apolipoprotein A-I', Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1042, pp. 227 - 236,
    Journal articles | 1989
    Rye KA, 1989, 'Interaction of the high density lipoprotein conversion factor with recombinant discoidal complexes of egg phosphatidylcholine, free cholesterol, and apolipoprotein A-I', Journal of Lipid Research, 30, pp. 335 - 346
    Journal articles | 1988
    Barter PJ; Rajaram OV; Chang LBF; Rye KA; Gambert P; Lagrost L; Ehnholm C; Fidge NH, 1988, 'Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apoliprotein A-IV as its activator', Biochemical Journal, 254, pp. 179 - 184,
    Journal articles | 1988
    Jonas A; Kezdy E; Williams MI; Rye KA, 1988, 'Lipid transfers between reconstituted high density lipoprotein complexes and low density lipoproteins: Effects of plasma protein factors', Journal of Lipid Research, 29, pp. 1349 - 1357
    Journal articles | 1986
    Rye KA; Barter PJ, 1986, 'Changes in the size and density of human high-density lipoproteins promoted by a plasma-conversion factor', Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 875, pp. 429 - 438,
    Journal articles | 1984
    Beckwith PLM; Fornasiero D; Horr T; Rye KA; Kurucsev T, 1984, 'POLYMER HEAT ENGINES: 1. STUDY OF POLY(VINYLAMINE) AND SOME OF ITS DERIVATIVES AS POTENTIAL WORKING SUBSTANCES IN HEAT ENGINES.', Polymer Communications (Guildford, England), 25, pp. 18 - 20
    Journal articles | 1984
    Hughes BP; Rye KA; Pickford LB, 1984, 'A transient increase in diacylglycerols is associated with the action of vasopressin on hepatocytes', Biochemical Journal, 222, pp. 535 - 540,
    Journal articles | 1984
    Rye KA; Barter PJ, 1984, 'Evidence of the existence of a high-density lipoprotein transformation factor in pig and rabbit plasma', Biochimica et Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 795, pp. 230 - 237,
    Journal articles | 1981
    FORNASIERO D; ROOS IAG; RYE K; KURUCSEV T, 1981, 'ChemInform Abstract: NEAR‐ULTRAVIOLET VIBRONIC TRANSITIONS OF ADENOSINE 5′‐PHOSPHATE, ADENOSINE, AND ITS COMPLEXES WITH CIS‐ AND TRANS‐DIAMMINEDICHLOROPLATINUM(II): SPECTRAL STUDY OF ISOTROPIC ABSORPTION, LINEAR DICHROISM, AND CIRCULAR DICHROISM', Chemischer Informationsdienst, 12,
    Journal articles | 1981
    Fornasiero D; Rons IAG; Rye KA; Kurucsev T, 1981, 'Near-Ultraviolet Vibronic Transitions of Adenosine 5'-Phosphate, Adenosine, and Its Complexes with cis- and trans-Diamminedichloroplatinum(II): Spectral Study of Isotropic Absorption, Linear Dichroism, and Circular Dichroism', Journal of the American Chemical Society, 103, pp. 1908 - 1913,
    Journal articles | 1971
    Krus S; Domaniewski J; Rye K, 1971, 'Relationship between the intensity of atherosclerosis and histological appearance of testicles.', Polish medical science and history bulletin, 14, pp. 83 - 85
  • Conference Papers | 2024
    Rakhshanda S; Liaw ST; Rhee J; Rye KA; Jonnagaddala J, 2024, 'Strategies to Improve Statin Medication Adherence Among Patients at Risk of Cardiovascular Disease Identified Through Electronic Health Records: A Literature Review', in Studies in Health Technology and Informatics, pp. 986 - 990,
    Preprints | 2023
    Manandhar B; Pandzic E; Deshpande N; Chen S-Y; Wasinger V; Kockx M; Glaros E; Ong KL; Thomas SR; Wilkins MR; Whan RM; Cochran BJ; Rye K-A, 2023, ApoA-I Protects Pancreatic β-cells from Cholesterol-induced Mitochondrial Damage and Restores their Ability to Secrete Insulin,
    Conference Abstracts | 2023
    Zhang Y; Glaros E; Hung T; Zhang R; Rayner BS; Wu B; Ku J; Cochran BJ; Devalaraja M; Thomas S; Rye KA, 2023, 'Abstract 623: A Novel Strategy For Reducing Future Events In Myocardial Infarction Survivors', in Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 43,
    Preprints | 2021
    Richardson A; Fok S; Lee V; Rye K-A; Di Girolamo N; Cochran B, 2021, Use of high-refractive index hydrogels and tissue clearing for large biological sample imaging (Preprint),
    Conference Papers | 2020
    Manandhar B; Cochran B; Rye K-A, 2020, 'Apolipoprotein A-I Increases Pancreatic beta-cell Insulin Secretion Bv Inhibiting Cholesterol-induced Oxidative Stress in Mitochondria', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, presented at American-Heart-Association's Scientific Sessions on Vascular Discovery - From Genes to Medicine, ELECTR NETWORK, 05 May 2020 - 07 May 2020,
    Conference Abstracts | 2020
    Ong KL; McClelland R; Allison MA; Cushman M; Garg P; Tsai MY; Rye KA; Tabet F, 2020, 'Association of Lipoprotein (a) and Coronary Artery Calcification: Prospective Study Assessing Interactions With Other Risk Factors in the Multi-Ethnic Study of Atherosclerosis', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 142
    Preprints | 2020
    Richardson A; Fok S; Lee V; Rye K-A; Di Girolamo N; Cochran BJ, 2020, Use of high-refractive index hydrogels and tissue clearing for large biological sample imaging,
    Preprints | 2020
    Tucker B; Sawant S; McDonald H; Rye K-A; Patel S; Ong KL; Cochran BJ, 2020, The Association of Serum Lipid and Lipoprotein Levels with Total and Differential Leukocyte Counts: Results of a Cross-sectional and Longitudinal Analysis of the UK Biobank,
    Conference Abstracts | 2020
    Vaidya K; Tucker B; Khandkar C; Pandzic E; Barraclough J; Misra A; Kavurma M; Rye K-A; Patel S; Cochran BJ, 2020, 'Colchicine Inhibits Neutrophil Extracellular Trap Formation in Acute Coronary Syndrome Patients Post Percutaneous Coronary Intervention', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 40, presented at American-Heart-Association's Scientific Sessions on Vascular Discovery - From Genes to Medicine, ELECTR NETWORK, 05 May 2020 - 07 May 2020,
    Preprints | 2020
    Vaidya K; Tucker B; Kurup R; Khandkar C; Pandzic E; Barraclough J; Machet J; Misra A; Kavurma M; Martinez G; Rye K-A; Cochran BJ; Patel S, 2020, Colchicine inhibits neutrophil extracellular trap formation in acute coronary syndrome patients after percutaneous coronary intervention,
    Conference Papers | 2020
    Vaidya K; Tucker BJ; Kurup R; Khandkar C; Barraclough J; Misra A; Kavurma M; Martinez G; Rye K-A; Patel S; Cochran BJ, 2020, 'COLCHICINE INHIBITS NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN ACUTE CORONARY SYNDROME PATIENTS POST PERCUTANEOUS CORONARY INTERVENTION', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, pp. E6 - E6,
    Conference Presentations | 2019
    Manandhar B; Cochran BJ; Rye K, 2019, 'APOLIPOPROTEIN A-I LOCALISES TO MITOCHONDRIA AND INHIBITS ROS GENERATION IN INSULIN PRODUCING CELLS.', presented at AAS 2019 Annual Scientific meeting, Victoria University City Convention Centre, Melbourne, 16 October 2019 - 19 October 2019
    Conference Presentations | 2019
    Tan WT; Kopecky C; Manandhar B; Rye K-A; Cochran B, 2019, 'Skeletal Muscle Specific Deletion Of Abca1 And Abcg1 Impacts Body Composition And Metabolism And Is Age Dependent', presented at 87th European Atherosclerosis Society Congress, 26 May 2019,
    Conference Presentations | 2019
    Tucker B; Rehan R; Vaidya K; Rye K; Cochran B; Patel S, 2019, 'Colchicine inhibits neutrophil extracellular trap formation in acute coronary syndrome patients', presented at Australian Atherosclerosis Society Annual Scientific Meeting, Melbourne, 16 October 2019 - 19 October 2019
    Conference Abstracts | 2018
    Cochran BJ; Pinheiro D; Prendecki M; Jones B; Cegla J; Lee V; Barter PJ; Murphy AJ; Rye K-A; Woollard KJ, 2018, 'PRO-ATHEROSCLEROTIC LOW-DENSITY NEUTROPHILS ARE PRESENT IN HYPERCHOLESTEROLEMIA', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, CANADA, Toronto, Vol. 32, pp. 39 - 40, presented at International Symposium on Atherosclerosis (ISA), CANADA, Toronto, 09 June 2018 - 12 June 2018,
    Conference Papers | 2018
    Cochran BJ; Trajanovska S; Sunn N; Rye KA; Ryder WJ, 2018, 'Development of 3D printing filaments for bespoke X-Ray phantoms', in 2018 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2018 - Proceedings, Institute of Electrical and Electronics Engineers (IEEE), AUSTRALIA, Sydney, pp. 1 - 3, presented at 2018 IEEE Nuclear Science Symposium and Medical Imaging Conference Proceedings (NSS/MIC), AUSTRALIA, Sydney, 10 November 2018 - 17 November 2018,
    Preprints | 2018
    Kopecky C; Pandzic E; Parmar A; Szajer J; Lee V; Dupuy A; Arthur A; Fok S; Whan R; Ryder WJ; Rye K-A; Cochran BJ, 2018, Translocator Protein Localises To CD11b+ Macrophages In Atherosclerosis,
    Conference Abstracts | 2018
    Kopecky C; Ryder WJ; Szajer J; Parmar A; Pandzic E; Rye K-A; Cochran BJ, 2018, 'The TSPO Radioligand 18F-PBR111 as a Pre-Atherosclerotic Lesion Detection Agent', in Atherosclerosis Plus, Elsevier, CANADA, Toronto, Vol. 32, pp. 145 - 146, presented at International Symposium on Atherosclerosis (ISA), CANADA, Toronto, 09 June 2018 - 12 June 2018,
    Conference Papers | 2018
    Kopecky CM; Ryder WJ; Szajer J; Parmar A; Pandzic E; Rye KA; Cochran BJ, 2018, 'Translocator Protein as Novel Marker for Early Atherosclerosis', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, CA, San Francisco, presented at Scientific Sessions of the American-Heart-Association on Vascular Discovery - From Genes to Medicine, CA, San Francisco, 10 May 2018 - 12 May 2018,
    Preprints | 2018
    Lai YC; Woollard KJ; McClelland RL; Allison MA; Rye K-A; Ong KL; Cochran BJ, 2018, The association of plasma lipids with white blood cell counts: Results from the Multi-Ethnic Study of Atherosclerosis,
    Conference Papers | 2018
    Ong KL; Hui N; Januszewski AS; Kaakoush NO; Xu A; Fayyad R; DeMicco DA; Jenkins AJ; Keech AC; Waters DD; Barter PJ; Rye K-A, 2018, 'Relationship of FGF21 Levels With Major Cardiovascular Events in Patients Treated With Atorvastatin (From the Treating to New Targets [TNT] Study).', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS
    Conference Papers | 2018
    Ong KL; McClelland RL; Allison MA; Kokkinos J; Wu BJ; Barter PJ; Rye K-A, 2018, 'Association of Elevated Circulating Fibroblast Growth Factor 21 Levels With Prevalent and Incident Metabolic Syndrome: The Multi-Ethnic Study of Atherosclerosis.', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS,
    Conference Papers | 2018
    Rawther T; Torres LFC; Rye KA; Tabet F, 2018, 'REGULATION OF LIPOPROTEIN(A) EXPRESSION BY MICRORNAS IN HUMAN HEPATOMA CELL LINE HEP3B', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, PORTUGAL, Lisbon, pp. E160 - E160, presented at 86th Congress of the European-Atherosclerosis-Society (EAS), PORTUGAL, Lisbon, 05 May 2018 - 08 May 2018,
    Conference Abstracts | 2017
    Ong KL; O'Connell R; Januszewski AS; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Scott RS; Taskinen MR; Waldman B; Colman PG; Best JD; Simes JR; Rye KA; Keech AC, 2017, 'Baseline Circulating FGF-21 Levels and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study', in DIABETES, AMER DIABETES ASSOC, CA, San Diego, Vol. 66, pp. A458 - A458, presented at 77th Scientific Sessions of the American-Diabetes-Association, CA, San Diego, 09 June 2017 - 13 June 2017,
    Conference Abstracts | 2017
    Wu BJ; Sun Y; Tang S; Ong KL; Barter PJ; Rye K, 2017, 'Apolipoprotein A-I Protects against Pregnancy-Induced Insulin Resistance in Rats', in DIABETES, AMER DIABETES ASSOC, CA, San Diego, Vol. 66, pp. A32 - A32, presented at 77th Scientific Sessions of the American-Diabetes-Association, CA, San Diego, 09 June 2017 - 13 June 2017,
    Conference Papers | 2016
    Arsenault B; Tabet F; Bao W; Petrides F; Hovingh GK; Boekholdt SM; DeMicco D; Rye KA; Waters D; Kastelein J; Barter P; Lambert G, 2016, 'IMPACT OF DIABETES, INSULIN RESISTANCE AND CETP INHIBITION ON CIRCULATING PCSK9 LEVELS IN PATIENTS AT HIGH CARDIOVASCULAR RISK: THE ILLUMINATE STUDY', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, AUSTRIA, Innsbruck, pp. E245 - E246, presented at Congress of the European-Atherosclerosis-Society (EAS), AUSTRIA, Innsbruck, 29 May 2016 - 01 June 2016,
    Conference Papers | 2016
    Tabet F; Hou L; Cochran B; Torres LFC; Barter PJ; Rye KA, 2016, 'LIPIDS AND LIPOPROTEINS. BETA CELL-SPECIFIC DELETION OF ABCA1 AND ABCG1 REGULATES THE INCREASE OF SMALL NUCLEOLAR RNAS IN ADIPOCYTES', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, AUSTRIA, Innsbruck, pp. E199 - E199, presented at Congress of the European-Atherosclerosis-Society (EAS), AUSTRIA, Innsbruck, 29 May 2016 - 01 June 2016,
    Conference Abstracts | 2015
    Cochran BJ; Hou L; Manavalan APC; Sultana A; Moore BM; Patel M; Tall A; Barter PJ; Rye KA, 2015, 'PANCREATIC BETA-CELL SPECIFIC DELETION OF ABCA1 AND ABCG1 PERTURBS GLUCOSE METABOLISM AND INCREASES ADIPOSITY IN MICE DUE TO SUBOPTIMAL PLASMA INSULIN LEVELS', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SCOTLAND, Glasgow, Vol. 241, pp. E3 - E3, presented at 83rd Congress of the European-Atherosclerosis-Society (EAS), SCOTLAND, Glasgow, 22 March 2015 - 25 March 2015,
    Conference Papers | 2015
    Kontush A; Tubeuf E; Le Goff W; Dauteuille C; Guillas-Baudouin I; Lhomme M; Patel M; Huby T; Chapman MJ; Rye KA; Lesnik P, 2015, 'PHOSPHATIDYLSERINE POTENTLY ENHANCES ANTI-INFLAMMATORY ACTIVITIES OF RECONSTITUTED HDL', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SCOTLAND, Glasgow, pp. E30 - E30, presented at 83rd Congress of the European-Atherosclerosis-Society (EAS), SCOTLAND, Glasgow, 22 March 2015 - 25 March 2015,
    Conference Papers | 2014
    Kontush A; Camont L; Lhomme M; Rached F; Le Goff W; Dauteuille C; Baudouin IG; Negre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Rye KA; Chapman MJ, 2014, 'PHOSPHATIDYLSERINE: A KEY PLAYER IN MULTIPLE BIOLOGICAL ACTIVITIES OF HDL', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E32 - E32, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014,
    Conference Abstracts | 2014
    Ong KL; Januszewski AS; O'Connell R; Jenkins AJ; Xu A; Sullivan DR; Barter PJ; Hung WT; Keech AC; Rye K-A, 2014, 'Fibroblast Growth Factor 21 and Cardiovascular Outcome Events in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study', in DIABETES, AMER DIABETES ASSOC, Vol. 63, pp. A295 - A295,
    Conference Papers | 2014
    Tabet F; Vickers KC; Torres LFC; Ammori B; Yadav R; Hama S; Liu Y; Schofield J; Barter P; Soran H; Rye KA, 2014, 'EFFECT OF BARIATRIC SURGERY ON HDL-ASSOCIATED MICRORNAS', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E32 - E33, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014,
    Conference Papers | 2014
    Van der Vorst EPC; Theodorou K; Plat J; Van Eck M; Rye KA; Bursill CA; Tas SW; De Winther MPJ; Biessen EAL; Donners MMPC, 2014, 'High density lipoproteins exert pro-inflammatory effects on macrophages via IKK2-and NIK-independent NF-kB activation', in CARDIOVASCULAR RESEARCH, OXFORD UNIV PRESS, SPAIN, Barcelona, presented at 3rd Congress of the ESC-Council-on-Basic-Cardiovascular-Science on Frontiers in Cardio Vascular Biology, SPAIN, Barcelona, 04 July 2014 - 06 July 2014,
    Conference Papers | 2014
    Weise CB; Toth CL; Landstreet SR; Taylor RC; Tabet F; Rye KA; Hofmeister LH; Harrison DG; Kon V; Vickers K, 2014, 'NOVEL HDL FUNCTIONS ASSOCIATED WITH INTERCELLULAR COMMUNICATION, ATHEROSCLEROSIS, AND CHRONIC KIDNEY DISEASE', in ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, SPAIN, Spanish Soc Atherosclerosis, Madrid, pp. E22 - E22, presented at 82nd Congress of the European-Atherosclerosis-Society (EAS), SPAIN, Spanish Soc Atherosclerosis, Madrid, 31 May 2014 - 03 June 2014,
    Conference Papers | 2013
    Bisoendial R; Roediger B; Jain R; Cavanagh L; Tak P-P; Rye K-A; Weninger W, 2013, 'TARGETING LYMPHATIC DYSFUNCTION IN RHEUMATOID ARTHRITIS BY HIGH-DENSITY LIPOPROTEIN', in ANNALS OF THE RHEUMATIC DISEASES, BMJ PUBLISHING GROUP, pp. 195 - 195
    Conference Papers | 2013
    Charlton FS; Bobek G; Mirabito K; Xu B; Makris A; Rye K; Hennessy A, 2013, 'THE PROTECTIVE EFFECT OF APOLIPOPROTEIN A-I ON MEAN ARTERIAL PRESSURE IN AN IN VIVO MODEL OF CYTOKINE-INDUCED HYPERTENSION IN PREGNANCY', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. E145 - E145, presented at 35th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA) / 39th Annual Scientific Meeting of the Australian-Atherosclerosis-Society (AAS), AUSTRALIA, Melbourne, 05 December 2013 - 07 December 2013,
    Conference Papers | 2013
    Tabet F; Lee S; Torres CL; Levin M; Drummond GR; Remaley A; Rye KA; Vickers K; Sobey CG, 2013, 'TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL CIRCUITRY IN THE BRAIN AFTER TRANSIENT AND PERMANENT ISCHEMIA', in HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, AUSTRALIA, Melbourne, pp. E157 - E158, presented at 35th Annual Scientific Meeting of the High-Blood-Pressure-Research-Council-of-Australia (HBPRCA) / 39th Annual Scientific Meeting of the Australian-Atherosclerosis-Society (AAS), AUSTRALIA, Melbourne, 05 December 2013 - 07 December 2013,
    Conference Abstracts | 2012
    Ong KL; Allison MA; Cheung BMY; Wu BJ; Barter PJ; Rye K-A, 2012, 'C-Reactive Protein Trends and Associations with Total Mortality in United States Adults between 1999-2010', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126,
    Conference Abstracts | 2012
    Ong KL; Rye K-A; O'Connell R; Jenkins AJ; Brown C; Xu A; Sullivan DR; Barter PJ; Keech AC, 2012, 'Long-term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-binding Protein 4 in Subjects With Type 2 Diabetes', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126,
    Conference Abstracts | 2012
    Wu BJ; Shrestha S; Ong KL; Johns DG; Barter PJ; Rye K-A, 2012, 'Effects of Cholesteryl Ester Transfer Protein Inhibition on Endothelial Repair and Function', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126,
    Conference Papers | 2011
    Arsenault BJ; Huijgen R; Boekholdt SM; Bao W; Tabet F; Petrides F; Rye K-A; DeMicco DA; Barter PJ; Kastelein JJ; Lambert G, 2011, 'Plasma PCSK9 Levels and Clinical Outcomes in the Treating to New Targets Trial: A Nested Case-Control Study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS,
    Conference Papers | 2011
    Charlton F; Xu B; Makris A; Rye K; Hennessy A, 2011, 'High density lipoproteins restore integrin switching in a model of pre-eclampsia', in Placenta, W B Saunders Company Ltd, London, England, pp. A94 - A94, presented at Meeting of the International-Federation-of-Placenta-Associations (IFPA), Geilo NORWAY, 14 September 2011 - 17 September 2011
    Conference Papers | 2011
    Charlton F; Xu B; Makris A; Rye K; Hennessy A, 2011, 'Protective effects of high density lipoproteins in a model of pre-eclampsia', in Placenta, W B Saunders Company Ltd, London, England, pp. A94 - A94, presented at Meeting of the International-Federation-of-Placenta-Associations (IFPA), Geilo NORWAY, 14 September 2011 - 17 September 2011
    Conference Abstracts | 2011
    Ong KL; Wu BJ; Cheung BMY; Barter PJ; Rye K-A, 2011, 'Arthritis: Its Prevalence, Risk Factors, and Association with Cardiovascular Diseases in the United States National Health and Nutrition Examination Survey 1999-2008', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 124,
    Conference Papers | 2009
    Fryirs M; Barter P; Tabet F; Heather A; Rye K, 2009, 'HIGH DENSITY LIPOPROTEINS (HDL) INCREASE PANCREATIC B-CELL INSULIN SECRETION', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD,
    Conference Papers | 2009
    Fryirs MA; Barter PJ; Appavoo M; Tuch B; Tabet F; Heater AK; Rye KA, 2009, 'High Density Lipoproteins Increase the Insulin Secretory Capacity of Pancreatic beta-Cells', in DIABETES, AMER DIABETES ASSOC, LA, New Orleans, pp. A426 - A426, presented at 69th Annual Meeting of the American-Diabetes-Association, LA, New Orleans, 05 June 2009 - 09 June 2009,
    Conference Papers | 2009
    Heather A; Li X-H; McGrath K; Rye K; Barter P, 2009, 'HIGH DENSITY LIPOPROTEINS (HDLS) INDUCE A MILD OXIDATIVE STRESS RESPONSE IN HUMAN ENDOTHELIAL CELLS THAT INCREASES CELLULAR ANTIOXIDANT PROTEIN EXPRESSION AND PROTECTS AGAINST INFLAMMATORY INSULT', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD,
    Conference Papers | 2009
    Liong E; McGrath K; Tan J; Li X-H; Dy V; Barter P; Rye K; Heather A, 2009, 'ROLE OF 3B-HYDROXYSTEROID-[DELTA]24 REDUCTASE IN MEDIATING THE ANTI-INFLAMMATORY EFFECTS OF HIGH-DENSITY LIPOPROTEINS IN ENDOTHELIAL CELLS', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD,
    Conference Papers | 2009
    Tabet F; Lambert G; Jenkins A; Barter P; Rye K-A, 2009, 'THE ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES OF APOLIPOPROTEIN (APO) A-I FROM DIABETIC PATIENTS ARE IMPAIRED', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD,
    Conference Papers | 2009
    Tabet F; Remaley A; Barter P; Rye K-A; Lambert G, 2009, 'THE 5A APOA-I MIMETIC PEPTIDE DISPLAYS ANTI-INFLAMMATORY AND ANTIOXIDANT PROPERTIES MEDIATED BY ABCA1', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD,
    Conference Papers | 2008
    Tabet F; Barter PJ; Rye K-A, 2008, 'Apolipoprotein A-I and reconstituted high-density lipoproteins inhibit NADPH oxidase activation and expression and increase superoxide dismutase levels in human macrophages in high glucose conditions', in ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, GA, Atlanta, pp. E87 - E87, presented at 9th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology, GA, Atlanta, 16 April 2008 - 18 April 2008,
    Conference Papers | 2006
    Barter PJ; Rye KA, 2006, 'The rationale for using apoA-I as a clinical marker of cardiovascular risk', in Journal of Internal Medicine, pp. 447 - 454,
    Conference Papers | 2006
    Gelissen I; Harris M; Rye KA; Quinn CM; Brown AJ; Kockx M; Cartland S; Packianathan M; Kritharides L; Jessup W, 2006, 'ABCA1 and ABCG1 act sequentially to mediate cholesterol export to apoA-I', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 541 - 541, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006,
    Conference Papers | 2006
    Taylor J; Rye KA; Sloane T; Gaus K; Ruberu K; Jessup W; Kritharides L, 2006, 'Exogenous apolipoprotein A-I promotes faecal sterol excretion in hypercholesterolemic rabbits', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 167 - 167, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006,
    Conference Papers | 2006
    Uehara Y; Zhang B; Tsuboi Y; Miura S; Abe S; Higuchi M; Urata H; Rye KA; Yamada T; Saku K, 2006, 'A novel therapeutic strategy for Tangier disease', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, ITALY, Rome, pp. 562 - 562, presented at 14th Meeting of the International-Society-of-Atherosclerosis, ITALY, Rome, 18 June 2006 - 22 June 2006,
    Conference Papers | 2003
    Kockx M; Wright J; Sloane T; Sviridov D; Fu Y; Chaddha M; Anantharamaiah G; Phillips M; Dean R; Rye K; Jessup W; Kritharides L, 2003, 'Apolipoprotein A-I-mediated secretion of apolipoprotein E has structural requirements distinct from those related to stimulation of cholesterol efflux', in ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, JAPAN, KYOTO, pp. 70 - 71, presented at 13th International Symposium on Atherosclerosis, JAPAN, KYOTO, 28 September 2003 - 02 October 2003,
    Conference Papers | 1998
    James M; vanReyk D; Rye K; Dean R; Cleland L; Barter P; Jessup W, 1998, 'Low density lipoprotein (LDL) in human inflammatory joint fluid.', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, pp. A487 - A487,
    Conference Papers | 1990
    Barter PJ; Chang LBF; Newnham HH; Rye KA; Rajaram OV, 1990, 'Roles of lecithin: Cholesterol acyltransferase, lipid transfer proteins and nonesterified fatty acids in plasma cholesterol transport', in Journal of Drug Development, Supplement, pp. 85 - 89

NSW Govt. Cardiovascular Research Capacity Program Senior Researcher Grant: Evaluation of an Innovative Dual Action, Anti-inflammatory Inhibitor Drug for Treating Coronary Artery Disease.

National Heart Foundation of Australia Vanguard Grant: A Novel Strategy for Reducing Future Events in Myocardial Infarction Survivors

NHMRC Ideas Grant: Preservation and Generation of Beta Cells in Type 1 Diabetes with Novel Mimetic Peptides

NHMRC Ideas Grant:A Novel, Dual-targeted Therapeutic Approach for Reducing Diabetes-accelerated Atherosclerosis

MRFF Cardiovascular Mission Grant:Development of novel, clinically viable strategies for reducing cardiac damage and preventing future events in myocardial infarction (MI) survivors by targeting inflammation

2012 American Heart Association ATVB Council Special Recognition Award in Arteriosclerosis

2015 American Heart Association ATVB Council Distinguished Achievement Award

2016 UNSW, Faculty of Medicine, School of Medical Sciences, Researcher of the Year Award

2017 American Heart Association ATVB Council Mentor of Women Award

2020: University of New South Wales, Faculty of Medicine Award for Academic Research Excellence

2021: Inaugural Fellow of the American Society of Biochemistry and Molecular Biology

2021: NSW Government Ministerial Award for Research Excellence

2021: UNSW School of Medical Sciences Mentor of the Year

2022: American Society of Biochemistry and Molecular Biology Mid-Career Leadership Award

2023: Jack Oram Award for Outstanding HDL Research

My Research Supervision

Thomas King (PhD)

Samson Ogumodede (PhD)

Iqra Haleem (PhD)

William Wang (Med Hons)